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The most exciting phrase to hear in science, the one that heralds new 
discoveries, is not, "Eureka!" ("I found it") but rather; 
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The aIms of this study were to address the importance of TLR signaling in the 
development of immunity following infection with either Mycobacterium tuberculosis or 
Trypanosoma brucei. 
Results presented here discuss the following: 
a. Evaluate the contribution of CD 14, TLR2, TLR4 and My D88 to the generation of 
a protective immune response following either low- or high-dose mycobacterial aerosol 
challenge. Collectively, a requirement for Toll signaling during a mycobacterial infection 
is shown using animals deficient in the adaptor protein MyD88. Consequently, screening 
of the individual PRR-deficient animals revealed a more pronounced role for TLR2 
during a mycobacterial infection as opposed to CD14 or TLR4. Here, TLR2-deficient 
animals were unable to clear systemic bacteria as well as wild-type controls, a result 
attributed to defective granulomatous responses in the lungs of TLR2-deficient animals. 
Dissection of the TLR2 phenotype revealed that animals lacking this receptor developed 
pulmonary immunopathology during an M tuberculosis infection, characterized by 
elevated levels of 1NF, IFN-y and IL-12p40, as well as increased numbers of CD4+ and 
CD8+ T cells. Data presented here indicates that TLR2 is required by macrophages to 
control a pulmonary M tuberculosis infection, and in its absence the host attempts to 
compensate for this deficiency by upregulating a Type 1 inflammatory response, 
ultimately resulting in immunopathology and chronic pneumonia. 
b. Evaluate the contribution ofCD14, TLRl, TLR2, TLR2 & 4, TLR9 and MyD88 
to the generation of a protective immune response following a standard T brucei intra-
peritoneal challenge. Here, MyD88-deficient macrophages are non-responsive towards 
both soluble variant-specific surface glycoprotein (sVSG) as well as membrane bound 
VSG (mfVSG) purified from T brucei. Infection of MyD88-deficient mice with either 
clonal or non-clonal stocks of T brucei resulted in elevated levels of parasitemia. This 











of infection, followed by moderately lower VSG-specific IgG2a antibody titers during the 
chronic stages of infection. Analysis of several Toll-like receptor (TLR)-deficient mice 
revealed a partial requirement for TLR9 in the production of IFN-gamma and VSG-
specific IgG2a antibody levels during T. brucei infections. The MyD88-dependent 
induction of an inflammatory response was also associated with infection-induced 
pathology in that animals lacking MyD88 were less anemic than wild-type controls. 
These results implicate the mammalian TLR family and MyD88 signaling in the innate 























1. General introduction 
1.1 Prologue 
The immune system protects the host from a range of microorganisms and toxins, but 
must overcome several complicated problems in order to achieve this. Firstly, the host 
should be able to distinguish molecular structures present on a diversity of pathogens, a 
task which should encompass a large variety of environmental microorganisms. 
Secondly, the ensuing response should be mediated within a relatively short period of 
time, particularly because of the rate of proliferation of organisms such as viruses and 
bacteria. However, although this response should be dynamic enough to eliminate the 
pathogen, it should not be so vigorous so as to damage host tissue. And finally, a system 
should be in place such that a mechanism of tolerance exists to prevent healthy tissues of 
the host from coming under attack 
The course of evolution has moulded the host's response to invading organisms 
such that very many of the host's earliest solutions remain in place along with the most 
recent. As a result, the host's immune response can be said to consist of an innate 
immune system forming the core of host defenses, and an acquired or adaptive immune 
system. In this regard, the innate immune system has been evolving for a far longer 
period of time than the acquired immune system, and is therefore in certain respects, 
more complicated and refined. 
The innate immune system comprises several independent lines of defense which 
function collectively to safeguard the integrity of the host. Quintessentially, the innate 
immune system is responsible for creating an environment in which host cells' survive 
and invading exogenous life forms do not. Such an inhospitable environment is aided by 
the secretion of various antimicrobial peptides by host cells, the function of which 
remains an integral part retained by the innate immune system to this day. In general, 
these peptides are encoded within the host's genome and with time, have become 
inducible rather than constitutively expressed. 
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In vertebrates, the development of a system used to eradicate toxins produced by 
microbes or other organisms involved the secretion of pathogen-specific soluble 
receptors, or immunoglobulins. The importance for the generation of an adaptive immune 
response therefore plays an important role in the battle against organisms such as viruses 
and bacteria, pathogens once thought to fall within the domain of protective innate 
immunity. Nevertheless, the development of a protective adaptive immune response is 
critically dependent on the innate immune system. Here, the production of cytokines such 
as tumor necrosis factor (TNF), IL-l, IL-6, or IL-12 by cells such as macrophages and 
dendritic cells are essential for the generation of adaptive immunity, without which the 
adaptive immune system is severely weakened. Thus, the initiation of an innate immune 
response is essential to multicellular life on this planet, and effectively tailors the 
developing adaptive immune response. Indeed, several primitive organisms such as 
sub vertebrates are able to survive without an adaptive immune response. Furthermore, 
circumstances that generate innate immunodeficiency disorders are more life-threatening 
than those that produce adaptive immune impairment. 
1.2 A brief history of Toll 
Studies performed on embryonic patterning in Drosophila initially identified Toll as a 
component of the Dorsal group, the Dorsal group being a set of genes responsible for 
encoding mutually complementing participants in a signaling cassette required for the 
optimal dorsal-ventral polarization of fly embryos (Anderson et al., 1985a; Anderson et 
al., 1985b). The fact that Toll was a central component in this signaling cassette led 
Nusslein-Vollhardt and colleagues to the realization that Toll in fact encoded a plasma 
membrane receptor bearing specificity for a protein ligand called Spatzle (Morisato & 
Anderson, 1994; Schneider et al., 1994). Indeed, it was found that Spatzle encoded a 
novel protein, which upon proteolytic processing became active, thereby determining 
where Toll was active (Morisato & Anderson, 1994). Thus, the identification of Toll was 
discovered in an area initially unrelated to the realm of immunity. 
Despite the establishment of Toll as a regulator of early embryogenesis, it was not 
until the early 1990s that a link between the Toll pathway in Drosophila and the 
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interleukin-l receptor (IL-IR)-NF-KB-signaling cascade in mammals was made (Gay & 
Keith, 1991; Heguy et al., 1992). In Drosophila, activation of the Toll pathway following 
contact with Spatzle propagated nuclear translocation of an NF-KB-like transcription 
factor via an intracellular signaling cascade (Letsou et al., 1991; Shelton et al., 1993; 
Grosshans et ai., 1994). Here, the contact between the adaptor Tube and a serine kinase 
called Pelle resulted in the phosphorylation and degradation of the IKB orthologue Cactus 
(Geisler et al., 1992), an inhibitor of a transcription factor called Dorsal (Ip et al., 1991). 
Dorsal was then able to regulate maternal-effect genes involved in dorsoventral 
patterning (Thisse et al., 1991; Pan et al., 1991). In mammals, signaling via the IL-IR-
NF-KB-cascade proceeds via a TollIIL-IR (TIR)-domain-containing transmembrane 
receptor, and it was this cytoplasmic domain that was found to have homology with Toll 
(Gay & Keith, 1991). 
At the time, it was known that in mammalian systems, IL-l could induce NF-KB 
translocation to the nucleus (Nonaka et al., 1990; Anisowicz et al., 1991; Bomsztyk et 
ai., 1991). This fact spurred two groups of Droso hila geneticists to independently 
identify KB motifs in the promoter sequences of insect genes known to encode 
antimicrobial peptides (Reichhart et ai., 1992; Rosetto et ai., 1995), Thus, apart from its 
role in embryonic development, Toll was suspected to control the expression of 
antimicrobial peptides in the insect host. In 1996, the requirement for Toll to protect an 
adult Drosophila from an Aspergillus fumigatus infection was the first report to link the 
Toll pathway with the regulation of an antifungal response (Lemaitre et ai., 1996). Here, 
in response to A. fumigatus, the production of an antifungal peptide called Drosomycin is 
dependent on the translocation of a reI family member called Dif, a homolog of Dorsal 
(Rutschmann et ai., 2000). As was observed for the developmental cascade (Geisler et 
ai., 1992), Spatzle was also required for the activation of Toll in response to A. fumigatus 
(Rutschmann et ai., 2000). Therefore, a model was established in which Toll functioned 
to control the expression of genes encoding antimicrobial peptides which in tum 
promoted studies aimed at linking activation of the Toll pathway and the cytokine-
induced activation ofNF-KB. 
In 1997, a human homologue of the Drosophila Toll termed human Toll (h-Toll) 













member of what was to be called the mammalian Toll-like receptor family of proteins. h-
Toll (subsequently known as Toll-like Receptor 4) was shown to consist of an 
extracellular domain laden with leucine-rich repeats (LRR) , and a cytoplasmic domain 
which shared homology with the cytoplasmic domain of the human interleukin (IL )-1 
receptor. As was seen for its Drosophila counterpart, h-Toll could stimulate the 
translocation ofNF-KB to the nucleus and induce the expression of genes coding for the 
inflammatory cytokines IL-l, IL-6 and IL-8. The subsequent molecular cloning of a class 
of human receptors in 1998 showed these proteins to have intra- and extracellular 
domains homologous to that of Drosophila Toll (Rock et al., 1998), indicating that these 
proteins could constitute an important component of immunity in humans. 
It was at this point in time that a series of purely genetic approaches identified 
Toll-like Receptor 4 (TLR4) as the mammalian protein required for recognition of LPS 
and transduction of the LPS signal across the plasma membrane (Poltorak et ai., 1998a,b). 
Here, Poltorak and colleagues were able to show that mutations in the Tlr4 gene present 
in two strains of mice, namely C3H1HeJ and C57BLlI0ScCr, were responsible for their 
LPS hyporesponsiveness. Through the application of positional cloning methods, the 
mutation in C3HIHeJ mice was attributed to the replacement of a conserved proline 
residue in the TLR4 cytoplasmic domain with that of a histidine (Poltorak et al., 1998b), 
while the Tlr4 locus in C57BLIl OScCr mice was entirely deleted (Poltorak et al., 1998b; 
Poltorak et al., 2000). By 1999, studies using gene-targeted mice in which the 
transmembrane and cytoplasmic regions of TLR4 were deleted, confirmed the results of 
Poltorak and colleagues showing that the induced Tlr4 mutation abolished responses to 
LPS (Hoshino et ai., 1999). 
Subsequently, thirteen mammalian TLR paraloques have been indentified 
(Beutler et ai., 2004). These constitute 10 TLR proteins in humans and 12 in mice, all of 
which have been shown to function as recognition receptors for various protozoal 
(Campos et ai., 2004; Scanga et ai., 2002), bacterial (Poltorak et al., 19983 ; Takeuchi et 
ai., 1999; Hayashi et al., 2001; Zhang et al., 2004), fungal (Meier et ai., 2003) and viral 
(Tabeta et ai., 2004; Heil et al., 2004; Diebold et al., 2004) ligands, thereby controlling 
















1.3 TLR ligand specificity 
The genetic approaches used by Poltorak and colleagues to identify the TLR involved in 
LPS hyporesponsiveness in mice spurred other labs to search for possible polymorphisms 
within the human Tlr4 gene. Indeed, TLR4 polymorphisms have been associated with 
endotoxin hyporesponsiveness in humans (Arbour et al., 2000). Here, the TLR4 
polymorphism was identified as an amino acid substitution, from aspartic acid to glycine 
at position 299 (D299G). Similar polymorphisms have subsequently been associated with 
predisposition towards septic shock resulting from gram-negative bacterial infections 
(Lorenz et al., 2002a), as well as an increased risk of premature birth (Lorenz et al., 
2002b). Nevertheless, human TLR4 has been shown to be critical in the innate immune 
response to LPS from Gram-negative bacteria and the receptor has subsequently been 
shown to be involved in signaling in response to a broad range of exogenous and 
endogenous molecules (Table 1). For example, several exogenous molecules that use 
TLR4 for signal transduction include the F protein of respiratory syncytial virus (Kurt-
Jones et al., 2000), the anti-tumour agent Taxol found in the Western yew Taxus 
brevi/olia (Kawasaki et aI., 2000), and an envelope protein found in a murine retrovirus 
(Rassa et al., 2002). A few endogenous ligands have been shown to signal via TLR4 
(Table I), although it is suspected that contaminating LPS was present in several of the 
protein preparations (Vabulas et al., 2002; Okamura et al., 2001; Smiley et al., 2001). 
This being said, although the principal TLR4 activator is LPS, some controversy exists as 
to whether LPS actually binds to TLR4. 
Preliminary experiments which suggested that an additional molecule was 
required for TLR4-mediated LPS signaling were proposed by Shimazu et al. (1999) in 
which overexpression of TLR4 did not confer LPS responsiveness on human embryonic 
kidney 293 cells. This additional molecule was subsequently identified as MD-2 
(Shimazu et al., 1999), and conferred LPS responsiveness by physically associating with 
the extracellular domain of TLR4. It is now known that not only TLR4 and MD-2 are 
involved in LPS responsiveness, but it has been shown that CD14 and MD-2 function 
collectively to present LPS to TLR4 (da Silva Correira et al., 2001). This receptor 

















of Taxol (Kawasaki et al., 2000). Although Taxol bears no structural similarity to LPS, it 
possesses several LPS-like activites including signal induction mediated by the TLR4-
MD2 complex (Kawasaki el al., 2000). 
Table 1.1 I Toll-like receptors and their ligands 
Receptor Ligand Origin of ligand Reference 
Exogenous ligands 
TLRI Triacyl lipopetides Bacteria and mycobacteria Takeuchi et af., 2002 
Soluble factors Neisseria meningitidis Wyllie et al., 2000 
TLR2 Lipoproteinllipopeptides Various pathogens AHprantis et aI., 1999 
Peptidoglycan Gram-positive bacteria Takeuchi et aI., 1999 
Lipoteichoic acid Gram-positive bacteria Schwandner et ai., 1999 
LipoarabinomannaJl Mycobacteria Means et al., 1999 
I Phenol-soluble modulin Staphylococclls epidennidis Hajjar et al., 2001 
GlycoillosltolphospboHpids Trypanosoma cruzi . Campos et a/~, 2001 
GlycoUpids Treponema maitophi/uin Opitz et al., 2001 
Porins Neisseria Massari et a/., 2002 
Atypical lipopolysaccharide Leptospira interrogans Werts et aI., 2001 
Atypical lipopolysaccharide Porphyromonas gingiva/is Hirschfeld et al., 2001 
ZY![t9'§~I;1 Fu.ngi !1nderbiJl et aZ., 1999a 
TLR3 Double-stranded RNA Viruses Alexopoulou et aI., 2001 
TLR4 Lipopolysaccharide Gram-negative bacteria Poltorak et af., J 998a 
Taxol Plants Kawasaki el aI., 2000 
Fusion protein Respiratory syncytial virus Kurt-Jones et aI., 2000 
Envelope protein Mouse mammary-tumour virus Rassa et aI" 2002 
HeaJ-shock Qrotein 60' ChlamJ,dia n.neumoniae BuM et al. 2002 
TLR5 FlageJlin Bacteria Hayashi et al. 2001 
TLR6 Diacyllipopeptides Mycoplasma Takeuchi et aI., 200 I 
Lipoteichoic acid Gram-positive bacteria Takeuchi et aJ., 1999 
Zymos;ln Fungi Ozinsky et al. 2000 
TLR7 Imidazoquinoline Synthetic compounds Hemmi et al., 2002 
Loxoribine Synthetic compounds Heil et al., 2003 
Bropirimine Synthetic compounds Heil et al., 2003 
Single-stranded RNA Viruses Diebold et al. 2004 
TLR8 Imidazoquinoline Synthetic compounds Jurk et al., 2002 
Single-stranded RNA Viruses Heil el al., 2004 
TLR9 CpG-containing DNA Bacteria and viruses Hemmi et al., 2000 
TLRIO N.D. N.D. -
TLR11 N.D. Uropathogenic bacteria Zhang et al., 2004 
Profilin-)ike protein Toxoplasma ~ondii Yarovinsky et al. 2005 
. Endogenous ligands 
TLR2 Heat-shock protein 70' Host Asea et al., 2002 
TLR4 Heat-shock protein 70 Host Vabulas et at., 2002 
Domain A of fibronectin" Host Okamura el al .• 200 1 
OJigos. of Hyaluronic acid' Host Tenneer et al., 2002 
Fibrinogen • Host Smiley et 01.,2001 
" It is possible that these ligand preparations, particularly those of endogenous origin, were contaminated with lipopolysaccharide and/or 
other potent microbial components, and as a result careful analysis is required to conclude that TLRs recognize the indicated endogenous 











Several reports have proposed that TLR2 is also involved in LPS signaling (Kirschning et 
aI., 1998; Yang et al., 1998), although it has been suggested that overexpression of TLR2 
promotes certain cell lines to become sensitized to minor non-LPS contaminants in LPS 
preparations (Heine et aI., 1999; Takeuchi et al., 1999; Underhill et al., 1999a). Indeed, it 
was later shown that highly purified LPS does not activate cells in a TLR2-dependent 
manner (Hirschfeld et al., 2000), although the receptor is involved in responses towards a 
structural variant of LPS from Leptospira and Prophyromonas (Werts et al., 2001; 
Hirschfeld et al., 2001). 
TLR2 is however the prImary receptor involved in responses towards 
lipoproteins. The immunostimulating activities of lipoproteins can be attributed to the 
presence of lipoylated NH2 termini present in a variety of gram-negative and gram-
positive bacteria, as well as mycoplasmas. TLR2 mediates cellular responses to 
lipoproteins derived from Borrelia burgdorfei, Treponema palladium, M tuberculosis 
and Mycoplasma fermentans (Hirschfeld et al., 1999; Aliprantis et al., 1999; Brightbill et 
al., 1999; Takeuchi et al., 20008), but is also involved in mediating responses to several 
infectious pathogens and their products (Table 1). As can be seen in the table, these 
include whole mycobacteria, mycobacterial lipoarabinomannan, whole Gram-positive 
bacteria, Treponema glycolipid, yeast cell walls, peptidoglycan (PGN) and the 
Trypanosoma cruzi glycophosphatidylinositol anchor (Lien et ai., 1999; Yoshimura et ai.~ 
1999; Schwandner et aI., 1999; Means et ai., 1999; Flo et aI., 2000; Opitz et al., 2001; 
Campos et ai., 2001). 
It was later discovered that TLR2 did not function independently in response to 
several ligands. Here, TLR2 ligand specificity and signal transducing ability was 
determined by heterodimeric interactions with TLRs such as TLRI and TLR6 (Ozinsky 
et ai., 2000). In this case, cytokine production by a macrophage cell line was dependent 
on the cytoplasmic portion of TLR2 functionally pairing with either TLRI or TLR6, 
while dimerization of the TLR2 cytoplasmic domain did not induce cytokine production. 
This effect was however dependent on the stimulus used. The detection of Gram-positive 
bacteria, PGN and zymosan is mediated by cooperative signaling between TLR2 and 
TLR6, while TLR2 functioned independently or with a TLR other than TLR6 to detect 



















between 1LRI and TLR2 were shown to be required for ara-lipoarabinomannan- and 
tripalmitoyl cysteinyl lipopeptide-stimulated cytokine secretion from mononuclear cells 
(Sandor et al., 2003), as well as responses towards the outer-surface lipoprotein (OspA) 
of Borrelia burgdorferi (Alexopoulou et al., 2002). Thus, although specific ligands 
activate cells in a TLR2-dependent manner, the formation of complexes consisting of 
additional 1LRs or helper proteins such as CD 14 enhance the signaling capacity of the 
cell. 
The capacity of a few 1LRs such as 1LR2 and 4 to recognize a variety of ligands 
is not shared by all of the members of the mammalian TLR family. In the case ofTLR5, a 
55-kD protein monomer obtained from both Gram-positive and Gram-negative bacterial 
flagella was identified as the only TLR5 ligand (Hayashi et al., 2001). However, the 
uptake and translocation of flagellin by cells requires that the flagellin filaments undergo 
depolymerization before affording recognition by TLR5 (Smith et al., 2003). Specific 
ligand affinities can also be afforded to TLRs involved in the recognition of nucleic-acid-
like structures (Table I). The first of the 1LRs found to recognize a nucleic acid structure 
was TLR9 (Hemmi et al., 2000). In these studies, TLR9-deficient mice were found to be 
non-responsive towards bacterial DNA. Here, 1LR9 was found to specifically recognize 
unrnethylated CpG motifs present in bacterial but not vertebrate DNA. As a result, the 
subsequent administration of CpG DNA is sufficient to protect against infections by 
intracellular pathogens such as Leishmania major and Listeria monocytogenes in mice 
(Elkins et al., 1999; Krieg et al., 1998; Zimmermann et ai., 1998). In terms of recognition 
of double-stranded (ds) RNA produced by several viruses during their replicative cycle, 
induction of type 1 interferons (lFN-a and -~) is believed to be mediated in part by TLR3 
(Alexopoulou et al., 2001). Studies showed that expression of human TLR3 in a dsRNA-
nonresponsive cell line induced NF -KB activation following stimulation with either 
dsRNA, or the synthetic dsRNA analogue polyinosinic-polycytidylic acid [poly(I:C)]. 
Furthermore, animals deficient in TLR3 showed reduced responses towards both dsRNA 
and poly(l:C) (Alexopoulou et ai., 2001), although some doubt exists as to whether TLR3 
is actually involved in the direct recognition of dsRNA. This stems from the fact that 
plasmacytoid dendritic cells are the principal cells in both human and mouse blood that 













Paturel et al., 2001), the problem being that TLR3 is not expressed in this cell type 
(Kadowaki et al., 2001). This would indicate that TLR3 is not the only receptor involved 
in the recognition of viral nuclear material. Indeed, it was later shown that the 
physiological ligand for TLR7 and TLR8 is in fact single-stranded RNA (Heil et al., 
2004; Diebold et al., 2004), thereby linking virus recognition by plasmacytoid dendritic 
cells to IFN production. 
Although TLR7 and TLR8 participate in the discrimination of nucleic-acid 
structures in viruses, there is evidence that they are also able to confer responsiveness 
towards several synthetic compounds (Hemmi et aI., 2002; lurk et al., 2002; Heil et al., 
2003). The first synthetic agonist shown to activate a TLR was the antiviral agonist 
imidazoquinoline resiquimod (R-848; Hemmi et al., 2002). Here, TLR7 was required for 
responsiveness towards imidazoquinoline R-848 in mice. At the same time however, 
another group showed that both TLR7 and TLR8 could independently mediate 
recognition of imidazoquinoline R-848 (Jurk et al., 2002), thereby suggesting a certain 
amount of redundancy among these receptors. Since then, the immunomodulators 
loxoribine and bropirimine have been shown to activate cells via TLR7 (Heil et al., 
2003), thereby introducing the concept of TLR-activating agents as tools that can be used 
in clinical applications. 
TLRs 7,8 and 9 not only have homologous structures and nucleic-acid-like ligand 
specificities, but all are localized intracellularly during cellular activation (Ahmad-Nejad 
et al., 2002; Heil et al., 2003). Here, the development of a monoclonal antibody raised 
against TLR9 enabled the intracellular localization of endogenous TLR9 in a mouse 
macrophage cell line (Ahmad-Nejad et al., 2002). Subsequently, TLR7 and 8 localized in 
the endosomal and/or lysosomal compartments (Heil et al., 2003), indicating that TLRs 7, 
8 and 9 formed a functional subgroup within the TLR family. In contrast to these 
findings, TLRs 1, 2 and 4 are located on the cell surface (Shimazu et al., 1999; Hajjar et 
al., 2002; Yang et al., 1999; Visintin et al., 2001), and are recruited to phagosomes only 
after activation by their respective ligands (Underhill et al., 1999a; Ozinsky et al., 2000). 
Therefore, the subcellular localization of different TLRs can be correlated to some 
extent with the molecular patterns of their ligands, which would indicate that in terms of 











immune cells by TLRs. This imparts an additional layer of complexity with respect to 
TLR-dependent activation of cells in that signaling pathways used by individmil TLR 
proteins may very well be tailored not only to the stimulus at hand, but also the cellular 
localization of the stimulus. 
1.4 TLR-signaling pathways 
Upon ligand binding, initiation of TLR signaling in mammals proceeds via a common 
cytosolic TIR domain (Dunne & O'Neill, 2003). This domain not only has sequence 
homology with the TIR domain of the IL-1R family, but when activated, enables the 
recruitment of cytosolic TIR domain-containing adaptor proteins. The first of these 
proteins to be described was myeloid differentiation primary-response protein 88 
(MyD88; Lord et al., 1990), initially identified as a gene induced during the 
differentiation of M1 myeloleukaemic cells into macrophages. The activation of MyD88 
ultimately results in the induction of an intracellular signaling cascade consisting of two 
separate signaling pathways, namely JUN N-termin l kinase (JNK) and NF-KB (Fig. 1.1; 
Akira & Takeda, 2004). 
1.4.1 The MyD88-dependent signaling pathway 
Initial studies using macrophages deficient in MyD88 showed that this adaptor molecule 
had a central role in the production of inflammatory cytokines induced by lipoproteins, 
peptidoglycan, CpG DNA, dsRNA, flagellin and imidazoquinolines (Takeuchi et al., 
2000a,b; Alexopoulou et aI., 2001; Hemmi et aI., 2002; Hacker et al., 2000; Schnare et ai., 
2000; Hayashi et al., 2001). These results indicated that microbial components 
recognized by the majority of TLRs relay that activation signal via MyD88. The adaptor 
protein MyD88 was found to consist of two separate domains, namely a TIR domain in 
the C-terminal portion of the protein that interacted with the TLR and IL-IR TIR 
domains, as well as an N-terminal death domain. In its activated state, the N-terminal 
domain of MyD88 interacts with a death domain-containing IL-IR-associated kinase 












and IRAK-4 (Li et al., 2002). Individually, IRAK-1 and IRAK-4 were shown to be 
important components in the cellular response towards IL-1 and LPS (Kanakaraj et al., 
1998; Thomas et al., 1999; Swantek et al., 2000; Suzuki et al., 2002), although IRAK-4 
proved to be the more essential component in the IL-1- and TLR4-dependent signaling 
pathways. 
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Figure 1.1 TLR-signaling: MyD88-dependent and -independent pathways 
Stimulation of different TLRs facilitates the activation of two pathways: the MyD88-
dependent and-independent pathways. The MyD88-dependent pathway involves the 
early phase of nuclear factor-KB (NF-tcB) activation, which leads to the production 
of inflammatory cytokines. The MyD88-independent pathway activates interferon-
regulatory factor (lRF3) and involves the late phase of NK-tcB activation, both of 
which lead to the production of IFN-~ and the expression of IFN-inducible genes . 











Ultimately, the lRAK homologs promoted association with tumour-necrosis factor 
(TNF)-receptor-associated factor 6 (TRAF6), which then lead to the activation of the 
IKK complex (inhibitor of nuclear factor-xB (lxB)-kinase complex). The IKK complex 
in turn sequestered NF-xB in the cytoplasm resulting in dissociation and nuclear 
translocation ofNF-xB (Akira & Takeda, 2004). As a result, cells deficient in MyD88 are 
non-responsive towards ligands for TLRl, 2, 3, 4,5, 7 or 9 in terms ofTNF and IL-12 
induction. 
1.4.2 The MyD88-independent signaling pathway 
There were however some inconsistencies in the notion that NF-xB activation was solely 
a result of MyD88-dependent signaling. This stemmed from experiments in which LPS 
was still capable of inducing NF-xB activation, albeit with delayed kinetics (Kawai et al., 
1999). This led to the conclusion that an additional signaling pathway must exist, even 
though MyD88 was shown to be important for LPS-induced production of inflammatory 
cytokines. Analysis of the MyD88-independent activation of LPS signaling revealed a 
second adaptor protein named TIR domain-containing adaptor molecule (TIRAP) or 
MyD88-adaptor-like (Mal; Fitzgerald et al., 2001; Horng et al., 2001). It was found that 
Mal participated in TLR4, but not TLR9 signaling, which suggested that it played a role 
in the LPS-induced NF-xB activation in MyD88-deficient cells. In these experiments, the 
addition of a cell-permeable TIRAP/Mal peptide abolished LPS-induced maturation in 
both wild-type and MyD88-deficient dendritic cells, indicating that TIRAP/Mal was 
involved in LPS-induced MyD88-independent signaling. Indeed, the generation of 
Mal/TIRAP deficient mice revealed a role for Mal/TIRAP in TLR4 signaling (Yamamoto 
et al., 2002a), however, it was also evident that neither Mal nor MyD88 were required for 
the TLR3-dependent activation of interferon-inducible genes. 
The MyD88-independent activation of interferon-inducible genes can therefore be 
attributed to the TLR3~ and TLR4-dependent activation of transcription factor IFN 
regulatory factor-3 (IRF-3). IRF-3 regulates IFN-f3 production, which then regulates a 
range of other genes (Sato et al., 2000; Iwamura et al., 2001; Taniguchi et aI., 2002). In 














believed to regulate the distinct TLR-dependent pathways leading to IRF-3 and NF-KB 
activation (Yamamoto et al., 2002b; Fitzgerald et al., 2003). 
Thus, depending on the stimulus at hand, activation of individual TLRs not only 
drive distinct signaling pathways, but this combined action ultimately affects the 
maturation of the cell in question. 
1.5 TLR activation of cells 
Most tissues of the body, in particular those present at mucosal surfaces, are interlaced 
with resident innate leukocytes macrophages, dendritic cells (DCs), and mast cells. In the 
event of a pathogen entering the body, pathogen recognition mediated by TLRs 
orchestrates the recruitment of leukocytes to the site of infection, in so doing activating 
tissue stromal cells, tissue-resident innate cells, and circulating leukocytes. 
TLRs expressed on epithelial cells of the respiratory, intestinal and urogenital 
tracts (Ashkar et al., 2003; Zhang et al., 2004), represent the first line of defense against 
invading pathogens. Activation of these TLRs by an invading pathogen results in the 
production of cytokines, antimicrobial peptides and chemokines (Kagnoff & Eckmann, 
1997; Hertz et al., 2003). Cellular recruitment is regulated by a combination of direct 
recognition of pathogen-associated molecular patterns (P AMPs) by the vascular 
epithelium, as well as epithelial chemokines produced by the luminal surfaces of both the 
local tissue as well as the draining lymph nodes. One such example is a mouse model of 
septic shock induced by systemic administration of LPS (Andonegui et al., 2003). In this 
model, the accumulation of neutrophils into the lungs is associated with pulmonary 
failure that results in sepsis-related death. Andonegui and colleagues showed that TLR4 
responsiveness by the vascular epithelial cells, but not the neutrophils, was required for 
the neutrophil sequestration into the lungs. In another study, the presence of TLR4 on 
both the epithelial and hematopoietic cellular compartments was required for a protective 
inflammatory response following infection with uropathogenic Escherichia coli 
(Schilling et al., 2003). Therefore, TLRs present on epithelial, endothelial and 
hematopoietic cells recognize P AMPs present in invading pathogens and play an 















Cells which comprise this initial inflammation-induced cellular infiltrate include 
neutrophils, NK cells, monocytes, basophils and eosinophils. Attempts to determine the 
extent of TLR expression on cells either recruited due to an inflammatory response or 
cells stimulated in vitro has been met with some difficulty. Discrepancies in TLR 
expression profiles have been attributed to species-specific differences in TLR 
expression, mRNA expression and responsiveness towards various TLR agonists, as well 
as the lack of reliable TLR antibodies. Nevertheless, analysis of TLR expression at the 
mRNA level has revealed that some TLRs are either positively or negatively regulated, 
depending on the cell type. In human neutrophils, mRNAs for TLRs 1 through 10 are 
expressed, with the exception of TLR3 (Hayashi et al., 2003). Neutrophils were 
responsIve towards LPS, zymosan and R-848, but could not be stimulated by CpG 
(Neufert et al., 2001). Similarly, NK cells have been shown to express TLR9 mRNA, but 
are non-responsive towards CpG stimulation (Hornung et al., 2002). Both eosinophils 
and mast cells express mRNAs for several TLRs, but are only responsive towards a few 
agonists. Here, eosinophils only respond to R-848 via TLR7, despite constitutive 
expression of TLRs 1, 4, 7, 9 and 10 mRNA (N gase et al., 2003), while mast cells 
express TLRs 1, 2, 4 and 6 but only respond to TLR2 and TLR4 agonists (McCurdy et 
al., 2003; Supajatura et al., 2001 & 2002). Monocytes pn the other hand express a variety 
of TLRs that ultimately drive their differentiation into either tissue macrophages or DCs, 
thereby contributing to the generation of adaptive immunity. 
The majority of papers investigating TLR expression profiles on DC subsets have 
used RT-PCR as a tool to detect individual TLRs. In addition to this, some studies have 
used inhibitors of endosomal pathways such as bafilomycin and chloroquine to determine 
the functional location of individual TLRs. Collectively, these reports have shown that 
TLRs 3, 7, 8 and 9 require an acidic environment for endosome maturation, while TLRs 
1,2,4,5 and 6 are solely expressed on the cell surface (Heil et al., 2003; Lee et al., 2003; 
Matsumoto et al., 2003; Ahmed-Nejad et al., 2002). Furthermore, murine and human 
DCs exhibit differential TLR expression patterns (Kadowaki et ai., 2001; Edwards et al., 
2003). In humans, CD11c+ myeloid DCs (mDCs) express TLRs 1,2,3,5,6 and 8, while 
freshly isolated plasmacytoid DCs (pDCs) express TLR7 and 9 (Hornung et al., 2002; 














influences TLR expressIOn profiles. During the differentiation of human blood 
monocytes into immature DCs, expression of TLRs 1, 2, 4 and 5 are progressively lost 
when cultured in the presence of IL-4 and granulocyte-macrophage colony-stimulating 
factor (Visintin et al., 2001). Here, the differentiation into immature DCs is also 
associated with the acquired expression of TLR3. In mice, TLR expression not only 
varies between DC subsets, but TLR expression and responsiveness also depends on 
whether the DCs are freshly isolated or derived in vitro (Table 1.2). 
Table 1.2 I Toll-like receptor expression by mouse and human dendritic-cell subsets* 
* Data compiled from Degli-Esposti & Smyth (2005) and is representative of numerous studies investigating TLR 
expression and function in DC subsets in mice and humans. Cells were either directly isolated or generated in vitro. 
The cytokines used to generate the latter populations are indicated in parentheses. 
t Values indicate that the expression of the TLR wa~ confirmed by a functional response to the relevant ligands. 
§ The splenocyte population did not respond to TLR4 ligands, but bone-marrow-derived DCs cultured with 
granulocyte/macrophage colony-stimulating factor (GM-CSF) did (Boonstra et al., 2003). 
II This DC subset was non-responsive towards towards R-848 (Edwards et aI., 2003), but did produce CC-chemokine 
ligand 5 (CCL5IRANTES) in response to R-848 (Ruggeri et al., 2002). 
~ Blood DCs do not express TLR4, but LPS responsiveness in this case might be mediated by TLR2 (Hertz et al., 2001). 
This is observed for murine splenic DCs which express low amounts of TLR4, whereas 
freshly isolated murine DC subsets do not respond when stimulated with LPS (Boonstra 
et al., 2003). In contrast, myeloid DCs generated with granulocyte-macrophage colony-
stimulating factor respond robustly when stimulated with LPS as a result of their high 
level of TLR4 expression (Boonstra et al., 2003). Nevertheless, the differential functions 
of DC subsets imparts a certain amount of elasticity in the generation of multiple effector 
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cell types such as T HI, CTL or B cell responses and depends on the cellular environment 
as well as the stimulus received (Kalinski et ai., 1999; Vieira et ai., 2000; Tanaka et ai., 
2000; Nagai et ai., 2003). 
The generation of an adaptive immune response coincides with the maturation of 
DCs and the presentation of processed peptides to naive T lymphocytes in the context of 
MHC molecules. Stimulation of naIve T lymphocytes initially occurs in the draining 
lymph nodes, and is associated with the TLR-induced downregulation of inflammatory 
chemokine receptors and an upregulation of the receptors for lymphoid chemokines 
(Sallusto et ai., 1998; Dieu et ai., 1998; Forster et ai., 1999; Gunn et al., 1999). Once 
inside the lymphoid tissue, DCs induce the activation and differentiation of T cells by 
presenting the peptide to the T cell receptor in the context of an MHC molecule. CD28 
expression on naive T cells is triggered by upregulating the co-stimulatory molecules 
CD40, CD80 and CD86 (Hoebe et aI., 2004). The differentiation of CD4+ T cells into 
either T HI or T H2 cells depends on the density of peptides presented by DCs, the 
cytokines secreted, and the types of costimulatory molecules expressed (Constant & 
Bottomly, 1997). A similar process occurs for the activation of CD8+ T cells, although 
memory CD8+ T cell responses require CD4+ T cell help (Janssen et al., 2003; Shedlock 
& Shen, 2003; Sun et al., 2003; Bourgeois et al., 2002). Thus, TLR recognition of 
P AMPs promotes the activation and maturation of DCs which in tum induce T cell 
activation and differentiation. 
Although the role of DCs in instigating an immune response is well established, 
recent reports suggest that natural killer (NK) cells may have a role to playas initiators of 
immunity (Carayannopoulos & Yokoyama, 2004). While the initial signals seem to 
originate from DCs, NK cells are thought to coordinate immunity through the activation 
and elimination DCs (Degli-Esposti & Smyth, 2005). This DC-NK-cell crosstalk occurs 
with DCs that have already been activated through TLR-mediated pathogen recognition, 
although some reports suggest that NK cells have a role to playas initiators of immunity 
in that they express some members of the TLR family (Hornung et al., 2002; Muzio et 
ai., 2000; Chalifour et aI., 2004). Direct activation ofNK cells through TLRs can induce 
the production of IFN-y and TNF thereby acquiring cytolytic activity against immature 















Finally, B-cell activation and antibody production can be linked to DC-B-cell 
interactions (MacPherson et ai., 1999), but also to TLR-mediated activation of B cells 
(Martin & Kearney, 2002). Here common bacterial components such as 
phosphatidylcholine can interact with TLRs present on B cells and promote T cell-
independent antibody responses (Martin & Kearney, 2002). Antigens derived from 
microbial organisms such as LPS and CpG DNA can also trigger polyclonal B cell 
activation (poltorak et ai., 1998b; Krieg et ai., 2002), which may potentially result in the 
production of autoreactive antibodies. Thus, in the case of B cells that express 
autoreactive membrane immunoglobulin, mechanisms have developed that control 
against autoantibody production elicited by TLR agonists (Rui et ai., 2003). 
Collectively, TLRs not only alert the immune system to the presence of microbial 
infection, but tailor the appropriate immune response towards a specific pathogen. 
Although TLRs play an important role in the induction of an adaptive immune response 
against infectious diseases, the activation of TLRs can also result in the development of 
autoimmune disorders. The balance between a protective or a harmful immune response 
is addressed in the following sections. 
1.6 Bacterial infection and septic shock 
Although TLR-mediated pathogen recognition is required for the initiation of an effective 
immune response, excessive TLR signaling during an acute bacterial infection can lead to 
sepsis, one of the primary causes of death in intensive care units in the United States 
(Bochud & Calandra, 2003). Sepsis and its most severe form, septic shock, are 
characterized as an uncontrolled systemic inflammatory response which can ultimately 
result in tissue injury, vascular instability and multiple organ failure. 
The development of septic shock can be directly linked to a hyperinflammatory 
immune response mediated by the activation of TLR4 and CD14 (Miller et ai., 2005). 
Here, endotoxin released in large quantities from Gram-negative bacteria results m 
excessive production of TNF and IFN-y, the major cytokines contributing to 
polymicrobial sepsis. Therefore, strategies aimed at blocking the toxic effects of LPS 
have in part focused on a temporary blockade of TLR4 signaling. The validity of such an 
18 
n l
V<.U'U. .... ,,,, n,"'Ttl"""" ..... DrC)te(;tr ' H(,fJ'AHHU UUU1",UA'" S.POlrlS
IS
IS  I1'e l 










approach is substantiated by the fact that mice having either a natural or induced Tlr4 
gene mutation are resistant to LPS-induced endotoxic shock (Poltorak et ai., 1998a,b; 
Hoshino et ai., 1999). Furthermore, animals lacking CD14 are resistant to LPS toxicity as 
well as Gram-negative-induced sepsis (Haziot et ai., 1996). The feasibility of inducing 
protection against sepsis in animals by administration of anti-CDl4 monoclonal 
antibodies has been evaluated in rabbit models (Schimke et ai., 1998), although treatment 
with monoclonal antibodies alone is not sufficient for full protection (Opal et aI., 2003). 
Similar approaches aimed at blocking TLR4 signaling during sepsis have focused on the 
use of specific analogues of LPS, which function as LPS antagonists, in so doing 
interfering with the recognition of LPS by TLR4. One such example is the LPS lipid A 
analogue E5564 which has been shown not only to pharmacologically interfere with 
TLR4-induced LPS signaling in vitro (Mullarkey et ai., 2002), but appears to be a 
potential therapeutic agent for Gram-negative sepsis (Lynn et aI., 2003). 
The use of TLR4 antagonists as a tool to curb septic shock should however be 
approached with caution. In humans, an amino acid substitution in TLR4 (D299G), has 
been associated with an increased risk of Gram-negative infections (Agnese et ai., 2002; 
Lorenz et ai., 2002a), as well as an increased incidence of systemic inflammatory 
syndrome (Child et ai., 2003). This being said, the effect of the human D299G 
polymorphism on sepsis can only be linked to Gram-negative infections as the same 
polymorphism does not affect polymicrobial sepsis (Feterowski et ai., 2003). 
1. 7 Allergic disease 
Over the past three decades there has been an increase in the prevalence of allergic 
diseases such as asthma. Presently, the design of treatments aimed at controlling the 
transition from allergic disease to asthma has been limited by a lack of understanding of 
the essential mechanisms involved in triggering chronic inflammatory disease. 
In asthmatics, chronic inflammatory disease has been associated with a prevailing 
T H2 response, although no mechanistic explanation is available for the selective 
activation of TH2 cells (El Biaze et ai., 2003; Hussain & Kline, 2003; Kuchroo et ai., 
2003). Mouse models of allergic airway disease have shown that stimulation of lung DCs 
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with low doses of inhaled LPS have induced a T H2 response and aIlergic inflammation, 
whereas increased doses of LPS have shifted the T H2-type inflammation to a T HI 
response (Eisenbarth et al., 2002). Physiologically, these experimental setups have 
correlated the low LPS doses to the amount of LPS present on inhaled environmental 
antigens, while higher LPS doses are associated with amounts present during Gram-
negative bacterial infections. In tenns of activation of the immune response, it is thought 
that the induction of a T H2 response following inhalation of environmental LPS is TLR4-
dependent, while the induction of a T HI response after Gram-negative infection is also 
TLR4-dependent. Nevertheless, one of the aims of treating asthma in believed to involve 
changing the Twcell balance from a dominant TH2-type inflammation to a TH1-type 
response. 
LPS has however been shown to have opposmg effects on allergic asthma. 
Studies on people with allergic asthma have not only shown that the severity of asthma 
induced by house mite allergen can be more closely correlated to LPS levels as opposed 
to the allergen itself (Michel et al., 1996), but are also more sensitive to the 
bronchoconstrictive effects of inhaled endotoxin (Michel et al., 1989). In contrast, 
exposure of LPS in early childhood may decrease the incidence of asthma later in life 
(Braun-Fahrlander et al., 2002; Gehring et al., 2002). This being said, the ability of LPS 
to exacerbate asthma and decrease atopy is not observed for individuals with the D299G 
polymorphism in that these individuals have a decreased risk of bronchoreactivity 
(Werner et al., 2003), and increased atopic severity (Yang et al., 2004). 
Mechanistic roles proposed for TLR4 in the development of asthma and atopy 
include the production of IL-IO by DCs which limit T HI inflammatory pathology 
(Higgins et al., 2003), and the LPS-induced activation of regulatory T cells which serve 
to curb THI inflammatory responses (Caramalho et al., 2003). This being said, a search 
for compounds that can be used for the treatment of allergy has identified R-848, the 
TLR 7 and TLR8 agonist, as a potential candidate (Brugnolo et al., 2003). Here, the 
characteristic T H2 response associated with allergen-specific CD4+ lymphocytes was 
shifted to a protective T HI response, indicating that the use of imidazoquinolines could 














1.8 Autoimmune disease 
The TLR-dependent activation of a pathogen-specific immune response has also been 
linked to the development of autoimmunity. In this setting, potentially self-reactive T 
cells in the peripheral circulation are kept in check by regulatory T cells (T R cells). T R 
cells therefore have a dual function in that they suppress the inflammatory responses of 
activated T cells, but also maintain tolerance to self antigens. Here, IL-6 produced by 
DCs in response to TLR activation makes antigen-specific T cells refractory to 
suppression by T R cells, allowing a pathogen-specific immune response to be mounted 
(Pasare et al., 2003), but also relieves suppression of auto-reactive T cells. 
The MRL-lpr murine model of systemic lupus erythematosus (SLE) and 
rheumatoid arthritis has supported a link between TLRs and autoimmune disease. Here, 
MRL-Ipr mice produce exceedingly high titres ofIgG anti-IgG rheumatoid factor (RF), a 
B-cell receptor with specificity toward self-IgGs (Theofilopoulos et al., 1985; Wolfowicz 
et al., 1988). Complexes of IgG bound to nucleosomes activate B cells from mice that 
express RF, a phenomenon also seen in SLE patients who have auto-antibodies that 
recognize nuc1eosomes and DNA (Tan et al., 1989). The link to TLR signaling comes 
from the fact that B cells from mice expressing RF but deficient in MyD88 do not 
respond to anti-nucleosome IgGs (Leadbetter et al., 2002). More specifically, TLR9 has 
been implicated in this as the TLR9 antagonist S-ODN 2088 (Leadbetter et al., 2002; 
Lenert et al., 2001) inhibits B cell proliferation. Furthermore, stimulation of TLR9 with 
CpG oligonucleotides is shown to break tolerance in an experimental autoimmune 
encephalomyelitis model of multiple sclerosis (Ichikawa et al., 2002), substantiating the 
role ofTLRs in breaking peripheral tolerance towards self-antigens. 
Apart from potential TLR antagonists that can be used to ameliorate autoimmune 
responses, a more dangerous approach would be to use high doses of LPS as a tool to 
induce suppression of auto-reactive T cells by TR cells (Caramalho et al., 2003). In this 
model, excessive doses of LPS increase the immunosuppressive effects of T R cells, in so 
doing describing a potential mechanism used by the immune system to minimize 













The stimulation of an immune response such that it resembles an infection, termed 
immunotherapy, is a strategy that has been used in several studies as a means to eliminate 
tumours (Heckelsmiller et al., 2002; Carpentier et al., 1999; Egeter et al., 2000). The 
general concept behind this type of approach is to prime an antigen-presenting cell such 
as a DC with a tumour-specific antigen, and then administer these cells together with 
microbial molecules such as CpG oligodeoxyribonuceotides. Indeed, such approaches 
have proved effective in reversing immune tolerance towards tumours (Heckelsmiller et 
al., 2002), ultimately curing animals of large solid tumours that are resistant towards 
chemotherapy. The TLR-dependent development of an immune response towards 
adjuvants such as CpG oligodeoxyribonucleotides has also been effective against 
neuroblastoma, lymphoma, melanoma, glioma, fibrosarcoma as well as lung carcinoma 
(Carpentier et al., 1999; Carpentier et al., 2000; Egeter et al., 2000; Ballas et al., 2001; 
Kawarada et al., 2001). 
1.10 TLR signaling and infection 
Although several studies have shown that TLRs expressed on various cell types are 
involved in the recognition of a large variety of P AMPs (Table 1.1), it has been difficult 
to identify roles for individual TLRs during in vivo infectious models. The majority of 
work done implicating TLR-signaling and its importance in an innate immune response 
have done so using animals deficient in MyD88. 
In terms of bacterial infections, MyD88 was shown to be essential for clearance of 
Staphylococcus aureus (Takeuchi et al., 2000C), Pseudomonas aeroginosa (Skerret et al., 
2004), group B streptococci (Mancuso et al., 2004), and ;\4ycobacterium avium (Feng et 
al., 2003), susceptibility being associated with impaired inflammatory cytokine 
production and elevated bacterial loads. The requirement for MyD88 during infection is 
not only restricted to bacterial models, but can be extended to protozoal infections as 
welL Here MyD88-deficient animals have reduced resistance towards Toxoplasma gondii 














ai., 2003), as well as the spirochete B. burgdorferi (Liu et ai., 2004). In tenns of the 
Leishmania model, susceptibility was associated with a polarized T H2 response that 
developed in the absence of the MyD88-dependent IL-12-mediated THI response 
(Muraille et al., 2003; Debus et al., 2003). 
Although attempts to dissect the MyD88-dependent activation of the innate 
immune response in tenns of the contributions made by individual TLRs have proved 
less successful, immune defects have been observed in some TLR models. TLR2-
deficient animals infected with Streptococcus pneumonia (Echchannaoui et al., 2002; 
Koedel et ai., 2003; Mancuso et al., 2004), S. aureus (Takeuchi et ai., 2000C) and 1. 
monocytogenes (Torres et al., 2004), have shown that TLR2 contributes to host resistance 
against these infections. In a model investigating immune responses towards M avium 
(Feng et ai., 2003), TLR2-deficient animals showed impaired host resistance and 
neutrophil responses to the bacterium, although such defects were not as severe as those 
observed for MyD88-deficient animals. Although TLR4 appeared to have a negligible 
role in resistance towards an M avium infection (Feng et ai., 2003), studies have shown 
that TLR4 plays a role in host defence against Haemophilus inJluenzae (Wang et ai., 
2002), Salmonella infections (Bernheiden et ai., 2001), as well as fungal infections 
caused by Candida aibicans (Netea et ai., 2002). Individually, functional roles for TLRs 
3, 5 and 11 have also been identified in vivo (Wang et ai., 2004; Hawn et al., 2003; 
Zhang et ai., 2004). Here, encephalitis caused by West Nile virus was attributed to viral 
entry into the brain mediated by TLR3 (Wang et ai., 2004), a stop codon polymorphism 
in the ligand-binding domain of TLR5 was associated with susceptibility to Legionella 
pneumophila (Hawn et ai., 2003), and preventing infection of internal organs of the 
urogenital system by uropathogenic bacteria has been linked to TLRl1 (Zhang et ai., 
2004). 
It should be noted however that the in vivo models in which individual TLRs 
contributed to overall host resistance were models where the pathogen of interest caused 
infection within a relatively short period of time. The more chronic the infection, the 
more difficult it has been to relate overall host resistance to an individual TLR (Feng et 
ai., 2003; Scanga et al., 2002; Adachi et ai., 2001; Reiling et ai., 2002). Here, pathogens 
such as Mycobacterium spp. and protozoan parasites have developed sophisticated 
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strategies for evading host immune responses. Indeed, these organisms produce long-
lasting chronic infections in order to maximize their opportunities for successful 
transmission. Results presented here discuss the bacterium Mycobacterium tuberculosis 
and the protozoan parasite Trypanosoma brucei, and the requirement for the TLR-
























2. Materials and methods 
2.1 Mice 
C3H/HeJ (containing Tlr4 point mutation) and C3H1HeN (C3HlHeJ wild-type controls) 
were obtained from Charles River Breeding Laboratories, Kisslegg, Germany. Animals 
deficient in TLRI (Takeuchi et ai., 2002), TLR2 (Michelsen et al., 2001), TLR9 (Hemmi 
et al., 2000), MyD88 (Kawai et al., 1999), TNF (Taniguchi et al., 1997), IFN-yR1 
(Huang et ai., 1993), IL-l R1 (Labow et al., 1997), and Caspase-1 (Kuida et al., 1995) 
were backcrossed onto a C57Bl/6 background 5 times or more. Mice deficient in TLR2/4 
were on a 129/SvJxC57Bl/6 background (Quesniaux et al., 2004b). CBAlJ mice were 
used as the corresponding wild-type controls for animals deficient in CD14 (Haziot et al., 
1996). Age matched control littermate mice of the corresponding genetic background 
were used in all experiments. Mice were obtained from either the University of Cape 
Town (Cape Town,South Africa) or the Transgenose Institute animal breeding facility 
(Orleans, France). All experiments performed were in accordance with the guidelines of 
the Animal Research Ethics Board of the University of Cape Town, South Africa, and the 
Regional Ethics Committee for Animal Experiments of Toulouse, France. 
2.2 Bacteria and infections 
M tuberculosis H37Rv (Abel et al., 2002) was grown in Middlebrook 7H9 broth (Difco, 
Detroit, MI) supplemented with Middlebrook OADC enrichment medium (Life 
Technologies, Gaithersburg, MD), 0.002% glycerol and 0.05% Tween 80. Pulmonary 
infection with M tuberculosis H37Rv of either 100 or 500 live bacteria was performed 
using a Glas-Col Inhalation Exposure System, Model A4224. Inoculum size was checked 
24 h after infection by determining the bacterial load in the lung of infected mice. 
2.3 Colony enumeration assay 
Bacterial loads in the lung, liver and spleen of infected mice were evaluated at different 
time points after infection with M tuberculosis H37Rv. Organs were weighed and 
defined aliquots were homogenized in 0.04% Tween 80 saline. Tenfold serial dilution of 
organ homogenates were plated in duplicates onto Middlebrook 7H10 agar plates 
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containing 10% OADC and incubated at 37°C for 19-21 days. Colonies on plates were 
enumerated and results are expressed as 10glO CFU per organ. 
2.4 Microscopic investigation of the lungs 
For analysis mice were sacrificed by carbon dioxide inhalation. Organs were weighed 
and fixed in 4% phosphate buffered formalin and paraffin-embedded. Two to 3-l-lm 
sections were stained with haematoxylin and eosin and a modified Ziehl-Nielsen method 
as described (Jacobs et al., 2000). For the immunostaining formalin-fixed paraffin-
embedded sections were deparaffinized and rehydrated and stained with rabbit anti-
mouse antibody specific for iNOS as described (Garcia et al., 2000). The sections were 
then washed in PBS and incubated for 30 min at room temperature with the biotinylated 
secondary antibody. The sections were incubated with avidin-biotin complexes (ABC 
vector kit) for 30 min, washed and incubated with DAB substrate (Dako). 
2.5 Lung homogenate preparations and FA CS analysis of cell surface markers 
Whole lungs were removed from infected mice at different time points and were 
homogenized in 1 ml 0.04% Tween 80 saline and supernatants were collected after low-
speed centrifugation, aliquoted and frozen at -80°C. Isolated lung cells were obtained by 
collagenase and DNAse treatment as described previously (Sallusto et al., 1999). The 
cells were counted and incubated with antibodies against CD3 (anti-CD3 PE, clone 145. 
2Cll), CD4 (anti-CD4 FITC, clone HI29.19), CD8 (anti-CD8 FITC, clone 53-6.7), 
CDlla (anti-CD11a PE, clone MI7/4), CD44 (anti-CD44 PE, clone IM7), CDllc (anti-
CDllc FITC, clone HL3), Ly-6G (anti-Ly6G FITC, clone RB6-8C5), I-AII-E (anti-I-AIl-
E PE, clone M51l14.15.2), CD16/32 (clone 2.4G2). All staining procedures were 
performed in PBS containing 0.1 % BSA, and 0.1 % sodium azide (F ACS buffer) for 20 
min at 4°C. All Abs were used at 0.2 I-lgll 06 cells and obtained from BD PharMingen 
(San Diego, CA). Cells were fixed with 4% paraformaldehyde for at least 1 h and 
analysed by flow cytometry. Cells were gated on the lymphocyte or monocyte population 
by forward and side scatter, and the data analysed using CellQuest software (BD 
Systems, San Jose, CA). 
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2.6 Preparation of elicited peritoneal macro phages 
Mice were injected with 1 ml of 4% thioglycolate (Difco). Five days later, peritoneal 
exudate cells were isolated from the peritoneal cavity by washing with ice-cold DMEM 
supplemented with 10% FCS (Life Technologies). Cells were cultured overnight and 
washed with DMEMl10% FCS to remove non-adherent cells. Adherent monolayer cells 
were used as peritoneal macrophages. Peritoneal macrophages (5x10scells/ml) were 
cultured in DMEMl10% FCS and stimulated with either LPS (E. coli, serotype 0111 :B4, 
Sigma; 100ng/ml) or M tuberculosis H37Rv (multiplicity of infection 2:1). Supernatants 
were harvested after 4 h. 
2.7 Antigen-specific IFN-r production 
For measuring antigen-specific production ofIFN-y, single cell suspension of splenocytes 
were prepared from wild-type and TLR2-deficient mice 4 weeks after infection with M 
tuberculosis H37Rv. Cells were resuspended in DMEM supplemented with 10% FCS, 
and penicillin and streptomycin (lOOU/ml and 100Jlg/ml; Life Technologies). 
Splenocytes were cultured at 5 x 105 cells/well in 96-well round-bottom microplates 
(Nunc, Naperville, IL), and stimulated with either 5Jlg/ml Con A (Sigma) or live M 
tuberculosis H37Rv (multiplicity of infection 2:1) at 37°C and 5% CO2. Supernatants 
were harvested after 3 days and stored at -80°C. 
2.8 CD4+ and CD8+ T cell enrichment 
Peripheral lymph nodes were obtained 4 wk after infection with M tuberculosis H37Rv 
and single cell suspensions were prepared in DMEM supplemented with 10% FCS, and 
penicillin and streptomycin (lOOU/ml and 100Jlg/ml; Life Technologies). Enrichment of 
CD4+ and CD8+ T cells was performed by negative selection with magnetic mouse anti-
B220-specific Dynabeads (Dynal, Robbins-Scientific, Mountain View, CA). Negatively 
enriched CD3+ T cell suspensions contained > 90% CD3 cells, as determined by flow 














2.9 Functional CD4+ and CD8+ T cell assay 
In vitro responses to mycobacterial Ag were measured as described previously (Kirman 
et al., 1999), with slight modifications: 4 x 105 CD3+ enriched lymph node cells obtained 
from C57BLl6 infected mice were cultured with 2 x 104 peritoneal macrophages pulsed 
with 2 x 105 M. tuberculosis H37Rv or IJlg of PPD for 4 h in antibiotic-free DMEM. 
Resident peritoneal macrophages were obtained 1 day before the experiment from 
peritoneal lavages of uninfected C57BLl6 and TLR2-deficient mice and incubated in 96-
well round-bottom microplates (Nunc) in complete DMEM. CD3+ T cells and pulsed 
macrophages were incubated for 96 h at 37°C and 5% C02. To determine mycobacterial 
Ag-specific IFN-y production, 100 JlI of supernatants from cultures were taken and kept 
frozen at -80°C. 
2.1 0 Parasites and experimental infection 
For clonal infections, the Antatl.lE clone of the EATRO 1125 stock of the pleomorphic 
blood-stream form was originally provided by Dr. N. Van Meirvenne (Institute of 
Tropical Medicine, Antwerp, Belgium). Frozen stabilate stocks of AnTatl.1 T bruce; 
used for infections were stored at -80°C at the Free University of Brussels. Mice were 
infected intra-peritoneally with 5 x 103 parasites diluted in PBS (pH 8.0) supplemented 
with 1.6% glucose. Animals were bled from the tail at intervals of either 1 or 2 days for 
the duration of the infection, and parasites were counted using a light microscope. 
2.11 Parasites and natural infection 
For infections of tsetse flies, male flies from the Glossina morsitans morsitans colony 
maintained at ITMA (Institute of Tropical Medicine, Antwerp) were used throughout the 
study. This colony was maintained on rabbits at 25°C and 65% relative humidity and is 
characterized by a high intrinsic vectorial capacity. Teneral flies (8-32 hrs after 
emergence) were fed their first bloodmeal on immune-suppressed NMRI mIce 
(cyclophosphamide (Endoxan ®), 80mg/kg), showing a parasitaemia of 108 parasites/ml 
of a pleiomorphic Tbrucei brucei AnT AR1 population, containing at least 70% short 
stumpy forms. After the infective meal, flies were maintained on uninfected rabbits for 












were starved for 72 hours and were forced to salivate on a pre-wanned (37°C) glass slide. 
This drop of saliva was examined for the presence of metacyclic trypanosomes. 
Metacyclic-infected tsetse flies were retained for the non-clonal infection experiments. 
2.12 s VSG, mjVSG and genomic DNA preparation 
Trypanosomes were harvested from infected blood by DE52 chromatography (Lanham, 
1968), using sterile PBS (PH 8.0) supplemented with 1.6% glucose for equilibration and 
elution. After separation, parasites were washed and resuspended in RPMI 1640 medium 
at a concentration of 109 parasites/mL sVSG was prepared from DE52-purified parasites 
by osmotic lysis for 5 min at 37°C in 10 mM sodium phosphate (PH 8.0) containing 0.1 
mM TLCK and 0.1 mM PMSF (Boehringer Mannheim). The supernatant was passed 
through a column of DE 52-equilibrated in 10 mM sodium phosphate (PH 8.0). sVSG was 
further purified on a column of Sephacryl-S200 (Phannacia Biotech), dialyzed against 
water overnight at 4°C, and freeze-dried. mfVSG was prepared according to the method 
previously described (Jackson et aI., 1985). VSG samples were incubated under gentle 
shaking for 2 h at room temperature with Prosep-Remtox (Bioprocessing, Princeton, NJ.) 
glass beads to remove possible LPS contamination. Following this, beads were separated 
by sample filtration over a 22-~lm sterile Spin-X centrifuge tube filter (Costar). Protein 
concentration of VSG was estimated by a detergent-compatible protein assay kit (Bio-
Rad Laboratories, Hercules, CA) using BSA as a standard. sVSG was resuspended in 
PBS (pH 8.0) and mfVSG was resuspended in PBS containing 0.02% N-octylglucoside 
(Sigma). For isolation of T. brucei DNA, DE52-purified parasites were lysed using 
TRIZOL ® (Invitrogen), and DNA was purified according to manufacturer's 
recommendations. DNA was resuspended in water and concentrations were determined 
by spectrophotometric analysis. Endotoxin units less than 0.5pg/mg VSG or DNA was 
determined using the LAL test (Bio Whittacher, Walkersville, MD). VSG preparations 
contained no T. brucei DNA. 
2.13 Primary macrophage cultures 
MyD88-deficient (Kawai et al., 1999), TLR9-deficient (Hemmi et al., 2000) and control 
murine bone marrow cells were isolated from femurs and cultivated (1 06/ml) for 7 days in 
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DMEM supplemented with 2 mM L-glutamine, 0.2 11M 2-ME, 20% horse serum and 
30% L929 cell-conditioned medium. Following this, cells were resuspended in cold PBS 
and recultured for 3 days in fresh medium at 37°C and 5% CO2. MyD88-deficient bone 
marrow-derived macrophages were plated in 96-well micro-culture plates at a density of 
105 cells/well. Culture medium used was DMEM containing 100V/ml penicillin, 100 
Ilg/ml streptomycin, 0.2 11M 2-ME and 2 mM L-glutamine. Cells were stimulated with 1 
Ilg/ml LPS (Escherichia coli, serotype 0111 :B4, Sigma-Aldrich, St. Louis, MO), 5 or 10 
Ilg/ml s VSG and 5 or 10 Ilg/ml mNSG both in the presence or absence of 30 V/ml IFN-
y. Similarly, TLR9-deficient bone marrow-derived macrophages were cultured with 1 
Ilg/ml LPS or 1.0 mg/ml, 2.5 Ilg/ml or 12.5 mg/ml T. brucei DNA in the presence of 30 
V/m1 IPN-y. All cells were stimulated for 24 in the presence of 50 V/m1 polymyxin B 
sulphate following which supernatants were harvested and frozen at -80°C. 
2.14 Quantification of anti-VSG serum titers 
Infection-induced anti-VSG serum titers were determined in a VSG solid phase ELISA. 
ELISA plates (Nunc) were coated in PBS (pH 8.0) with purified sVSG (10 Ilg/ml- 100 
ilL/well) by overnight incubation at 4°C. Free binding sites were blocked by an 
additional overcoat of BSA (1 mg/ml - 300 ilL/well, 1 hour incubation at 37° C). Serial 
serum dilutions were added to the plates and incubated overnight, following which plates 
were extensively washed with PBS. Detection of bound serum antibodies was done using 
1/1000 dilutions of IgM, and IgG isotype-specific HRP coupled antibodies 
(SouthernBiotech), followed by TMB substrate addition. After 20 minutes, the substrate 
conversion reaction was stopped by addition of 50111 1 N H2S04 and ODs were measured 
at 450 nm. 
2.15 Cytokine ELISA 
Supernatants were harvested and assayed for cytokine content using commercially 
available ELISA reagents for TNF-a, IFN-y and IL-12p40 (R&D Systems, Abingdon, 
VK and BD PharMingen, San Diego, CA). 
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2.16 Nitrite Measurements 
Nitrite concentrations in freshly obtained lung homogenate supernatants were determined 
using the Griess reagent (3% phosphoric acid, 1% p-aminobenzene-sulphonamide, 
1% n-1-napthylethylenediamide) as described (Reis e Sousa et al., 1997). 
2.17 Statistical Analysis 
Data were analysed by comparison of wild-type and gene-deficient mice at each time 
point, with 4-6 mice per time point. All graphic-result presentations were prepared using 
the GraphPad Prizm software. The same software was used for statistical analysis of data 
(student t test) and comparative analysis of survival data using a designated GraphPad 
Prizm statistical module, here values of p ::; 0.05 were considered significant. Each 



























Mycobacterium tuberculosis as a model for innate immunity 
Summary 
Recognition of Mycobacterium tuberculosis by the innate immune system is essential in 
the development of an adaptive immune response. Innate pattern recognition receptors 
(PRRs) implicated in the recognition of M tuberculosis include CD14, TLR2 and TLR4. 
However, a large variety of mycobacterial cell wall components activate macrophages 
through TLR2, suggesting that this innate immune receptor might have a predominant 
role in the host response to M tuberculosis infection. Results presented here show that 
MyD88, and by inference TLRs, are required by the host to control and aerogenic M 
tuberculosis infection. Individually, animals lacking TLR2 were more susceptible to an 
aerogenic mycobacterial infection than animals lacking either TLR4 or CD14. Here, 
TLR2-deficient animals were unable to clear systemic bacteria as well as wild-type 
controls, a result attributed to defective granulomatous responses in the lungs of TLR2-
deficient animals. Dissection of the TLR2 phenotype revealed that animals lacking this 
receptor developed pulmonary immunopathology during an M. tuberculosis infection, 
characterized by elevated levels of TNF, IFN-y and IL-12p40, as well as increased 
numbers of CD4+ and CD8+ T cells. Data presented here indicates that TLR2 is required 
by macrophages to control a pulmonary M tuberculosis infection, and in its absence the 
host attempts to compensate for this deficiency by upregulating a Type 1 inflammatory 












The global resurgence of tuberculosis has intensified research efforts directed at 
identifYing the role of immune cell activation by M tuberculosis. Protective cell-
mediated type I immune responses playa critical role in host defense against intracellular 
M tuberculosis infection. The secretion of type 1 cytokines by Ag-specific T cells play 
an important role in protective granuloma formation and stimulate the antimicrobial 
activity of infected macrophages, allowing intracellular microbial killing (Flynn et al., 
2001). 
The discovery of the TLR protein family and its importance in mediating immune 
responses has provided novel insights into mechanisms linking innate and adaptive 
immunity. The number of members of human and mouse TLRs thought to participate in 
innate immunity has grown, and evidence suggests a role for TLRs in the activation of 
immune cells by M tuberculosis (Takeda et al., 2003; Underhill et al., 1999'). In this 
context it has been proposed that initial recognition of mycobacterial components may 
involve other PRRs such as CDI4, scavenger and complement receptor and DC-SIGN in 
addition to members of the TLR family (Takeda et al., 2003; Quesniaux et al., 2004a). In 
terms of the TLR protein family, TLRs 2 and 4 have been implicated in the recognition of 
mycobacterial ligands (Brightbill et al., 1999; Jones et al., 2001; Means et al., 1999), 
although these results were largely based on in vitro studies. More specifically, it was 
shown that M tuberculosis-induced ThTF production was largely TLR2-dependent 
(Underhill et al., 1999b; Takeuchi et al., 1999), and that immunostimulatory responses to 
M tuberculosis 19-kDa lipoprotein, lipoarabinomannan (LAM) and mannosylated 
phosphatidylinositol (PIM) could be attributed to TLR2 signaling (Brightbill et al., 1999; 
Jones et al., 2001; Means et al., 1999). In addition to the aforementioned TLR2 agonists, 
heat-sensitive membrane-associated factors associated with M tuberculosis have been 
shown to activate cells via TLRs 2 and 4 (Lien et al., 1999; Means et al., 1999). This 
being said, the accumulation of in vitro data points towards TLR2 as the more dominant 
TLR involved in recognition of M tuberculosis ligands. This was further corroborated by 
direct killing of M tuberculosis in both mouse and human macrophages as a direct result 

























Uszynski et al., 2001). Here, the TLR2-dependent activation of murine macrophages led 
to NO-dependent growth inhibition of intracellular M tuberculosis, whereas human 
monocyte cultures displayed antimicrobial activity dependent on TLR2 but independent 
of both NO and TNF. It should be noted however that in addition to recognizing various 
mycobacterial ligands, several reports suggest that TLR2 may have a role to play in 
immune evasion by M tuberculosis (Noss et al., 2000 & 2001; Ramachandra et al., 2001; 
Pai et al., 2003; Tobian et al., 2003). 
One of the mechanisms used by M tuberculosis that allow the bacillus to survive 
for prolonged periods of time in the presence of vigorous CD4+ T cell responses is to 
prevent Ag processing or MHC-II expression by infected macrophages, thereby 
preventing recognition of infected macrophages by effector CD4+ T cells (Gercken et al., 
1994; Hmama et al., 1998; Noss et al., 2000). TLR2 has been implicated in this process 
of immune evasion in that M tuberculosis 19-kDa lipoprotein was identified as a major 
inhibitor of macrophage MHC-II expression and Ag processing (Noss et al., 2001). 
Furthermore, inhibition of IFN-y-induced class II transactivator expression and alternate 
class I MHC antigen processing by M tuberculosis 19-kDa lipoprotein (Pai et al., 2003; 
Tobian et al., 2003), demonstrate that PAMPs can also induce counter-regulatory or 
inhibitory effects via PRRs such as TLR2. 
Results presented in this chapter argue that animals require My D88 to control an 
M tuberculosis infection. At the ltbvel of individual PRRs, in vitro studies implicated 
CD 14, TLR2 and TLR4 in innate recognition of mycobacterial bacilli. Upon 
mycobacterial infection, TLR2 is shown to have a more pronounced role during infection 
than either CD14 or TLR4, although both CD14 and TLR4 are likely to contribute to 
overall host resistance. Dissection of the TLR2 phenotype revealed that animals lacking 
this receptor developed pulmonary immunopathology during an M tuberculosis 
infection, characterized by inflamed lungs and an increased T-cell infiltrate. The lack of 
functional granulomas during the chronic stages of infection accompanied by chronic 

























3.2.1 MyD88-deficient mice are unable to control an aerosol M. tuberculosis infection 
Infection of MyD88-deficient mice with 100 CFU live mycobacteria resulted in a 
bacterial burden in the lungs consistently higher than that observed for wild-type controls 
at each time point examined (Fig 3.1a), reaching approximately 3 IOglO difference at the 
time of death. The elevated pulmonary infection in My D88-deficient animals was 
accompanied by bacterial dissemination into the liver and spleen with the resulting 
bacterial load approximating 1.5 IOglO higher than that observed for wild-type controls 
(Fig. 3.1b-c). All MyD88-deficient mice died by 12 weeks post-infection (Fig. 3.1d;p < 
0.0001), but survived longer than animals deficient in TNF (Fig. 3.ld; P < 0.0001). 
Collectively, the enhanced susceptibility of MyD88-deficient mice towards an M 
tuberculosis infection suggests a role for PRRs/TLRs in the initial activation of an innate 
immune response. 
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Figure 3.1 MyD88-deficient mice are susceptible to an aerogenic M. tuberculosis infection. Control (-), 
MyD88- (0) and TNF-deficient mice (c) were aerogenic ally infected with 100 CFU M tuberculosis. CFU 
counts were determined at the indicated time points in the lungs (a), liver (b) and spleen (c). Survival of 











3.2.2 Progression of an aerosol M. tuberculosis infection in animals deficient in either 
CD14 or TLR2 
Gene-deficient animals and their corresponding wild-type controls were infected 
aerogenically with 100 live mycobacteria per animal. Animals deficient in CD 14 
controlled the infection as well as wild-type controls and exhibited no differences in 
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Figure 3.2 M. tuberculosis CFU counts in the lungs, livers and spleens of aerosol-infected animals 
deficient in CD14 and TLR2. Control (.) and deficient mice (0) mice were aerogenically infected with 100 
CFU M. tuberculosis. CFU counts were determined at the indicated time points in the lungs (a & d), liver 











Animals deficient in TLR2 infected with the same dose of M tuberculosis experienced 
no change in clinical status but exhibited 1 10gJO higher bacterial loads in the lungs 
compare to wild-type controls at 5 months post-infection (Fig 3.2d). The heightened 
pulmonary infection in TLR2-deficient animals was accompanied by bacterial 
dissemination into the liver and spleen with the resulting bacterial load exceeding that 
found in wild-type controls (Fig. 3.2e-f). A partial requirement for TLR4 in controlling 
local growth and dissemination of an aerosol M tuberculosis infection was previously 
shown by Abel et al. (2002). Here, infection of C3HIHeJ and C3HIHeN mice with 100 
CFU mycobacteria resulted in approximately 1 10gJO higher bacterial loads in C3H1HeJ 
mice in the lung, liver and spleen during the chronic stages of infection. Thus, a similar 
disease phenotype is observed for animals deficient in either TLR2 or TLR4 during the 
chronic stages of infection when infected with 100 CFU mycobacteria. 
3.2.3 High dose aerosol M. tuberculosis infoction ojCD14-, TLR2- and TLR4-deficient 
mice 
Aerosol M tuberculosis infections delivering 100 CFU per animal are used as a 
standard/low dose in the majority of models investigating progression of the disease 
(Turner et al., 2003; Saunders et al., 2002; Cowley et al., 2003; Feng et ai., 1999). In 
these systems, distinct phenotypes only become apparent should the missing molecule 
have a nomedundant role. In terms of infections investigating molecules involved in the 
innate immune recognition of M tuberculosis, experimental setups using higher doses of 
mycobateria would allow compensatory processes to be minimized. This type of 
approach has been supported by infectious models investigating roles of individual TLRs 
involved in host response towards bacilli such as S. aureus (Takeuchi et al., 2000) and 
group B streptococci (Mancuso et al., 2004). 
In this regard, we increased the infectious dose of aerogenic ally delivered 
mycobacteria from 100 CFU to 500 CFU per mouse. Animals deficient in CDI4, TLR4, 
TLR2 and the corresponding wild-type controls were infected with 500 CFU 
mycobacteria in an attempt to determine whether an individual PRR had a more 
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Figure 3.3 Survival of CD14-, TLR2- and TLR4-dejicient mice following aerosol infection with M, 
tuberculosis. Wild-type (.) and deficient mice (0) were aerogenically infected with 500 CFU M 
tuberculosis, CBA/J and CD14+ mice (a; 9 mice per group), C3H1HeN and C3H/HeJ (b; 10 mice per 
group) or C57BV6 and TLR2-1- mice (c; 10 mice per group) were monitored for survival. Moribund mice 
were sacrificed, Survival rates of C57BV6 and TLR2'/- mice were significantly different (p < 0.0005). 
No difference in survival was observed for either CD 14- or TLR4-deficient animals when 
compared to wild-type controls (p> 0.05; Fig. 3.3a & b). However, all TLR2-deficient' 
mice were unable to control the infection (Fig. 3.3c), with all animals succumbing to 
infection by 22 weeks (Fig. 3.3c; p < 0.0005). Wild-type mice controlled the same 
infectious dose and appeared healthy at 7 months post-infection at which point the 
experiment was terminated. This would indicate that TLR2 contributes to host resistance 
against M tuberculosis more so than either CD14 or TLR4, although genetic 
backgrounds do play a role in increased susceptibility towards high dose aerosol 
infections (Pan et al., 2005; Fig. 3.3). Nevertheless, due to the more susceptible 
phenotype observed for the deficiency in TLR2 during 500 CFU challenges, experiments 
were performed in an attempt to characterize the immune response towards an M 











susceptibility observed for TLR2-deficient mice was accompanied by 1 10glO higher 
mycobacterial burdens in the lungs at weeks 8 and 14 post-infection when compared to 
wild-type controls (Fig. 3.4a). The augmented pulmonary infection present in TLR2-
deficient animals resulted in dissemination of bacilli into the liver at week 8 (Fig. 3.4b) as 
well as the spleen at week 14 (Fig. 3.4c). 
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Figure 3.4 TLR2-dejicient mice are unable to control an aerosol M. tuberculosis infection effectively. 
Wild-type (_) and TLR2-deficient mice (0) were aerogenicaUy infected with 500 CFU M. tuberculosis. 
CFU counts were determined at the indicated time points in the lungs (a), liver (b) and spleen (c). *,p < 
0.05; **,p < 0.01. 
Therefore, a deficiency in TLR2 resulted in elevated bacterial burdens in the lungs, liver 
and spleen following either 100 or 500 CFU mycobacterial infections. To determine 
whether this could be partly attributed to a defective granulomatous response in the lungs, 











3.2.4 TLR2-dejicient mice develop a defective granulomatous response 
Following a standard/low dose 100 CFU mycobacterial challenge, animals deficient in 
TLR2 showed an increased number of bacilli in the lungs at S months post-infection (Fig. 
3.2d). The lungs of wild-type and TLR2-deficient mice were examined histologically at 
this time point to determine whether the elevated bacterial numbers could be correlated 
with a defective granulomatous response (Fig. 3.S). Lung micrographs of wild-type 
animals showed robust mononuclear cell infiltration with abundant focal lymphocytes, 
suggesting that the infection was controlled (Fig. 3.Sa). However, microscopic 
investigation of the lungs of TLR2-deficient mice revealed coalescent inflammatory 
lesions, reduced airspace and an absence of proper granuloma formation (Fig. 3.Sb). 
Figure 3.5 TLR2-deJicient mice exhibit defective granuloma formation in response to M. tuberculosis 
infection. Lung tissue taken from wild-type (a) and TLR2·/· mice (b) 5 months after aerosol infection with 
100 CFU M. tuberculosis. Low-power micrographs of representative lung sections are shown 
(magnification, x40). 
The presence of inflammatory pathology in TLR2-deficient animals at S months post-
infection warranted examination of the granulomatous response in these animals 
following SOD CFU M tuberculosis infection (Fig. 3.6). Here, microscopic analysis of the 
lungs of wild-type and TLR2-deficient mice at 2 weeks post-infection showed 
comparable thickening of alveolar septae, with no discemable granulomatous structures 
(Fig. 3.6a & b). By 4 weeks post-infection, wild-type mice had developed typical 

















Figure 3.6 Defective granuloma formation in TLR2-dejicient mice is associated with an exaggerated 
inflammatory response. Lung tissue from wild-type (left column) and TLR2-deficient mice (right column) 
was analysed following 500 CFU M tuberculosis infection. Lungs removed at days 14 (a & b), 28 (c & d), 
















epithelioid macrophages, as well as lymphocytic perivascular and peribronchiolar cuffing 
(Fig. 3.6c). TLR2-deficient mice exhibited a diffuse recruitment of inflammatory cells, 
thickening of the alveolar septae and interstitial pneumonia (Fig. 3.6d). A significant 
difference in lung architecture was however seen at 8 weeks post-infection (Fig. 3.6e & 
f). While wild-type mice lung sections displayed compact epithelioid granulomas 
containing dense infiltrations of lymphocytes (Fig. 3.6e), TLR2-deficient lungs showed 
massive coalescent inflammatory lesions, focal necrosis, diffuse foamy macrophages, 
substantial perivascular cuffing and very few granulomatous structures (Fig. 3.6f). 
Macroscopically, TLR2-deficient lungs were swollen, displayed pleural adhesions, and 
were significantly larger than the lungs of wild-type controls (Fig. 3.9a). This phenotype 
was also seen in TLR2-deficient animals at 5 months post-infection (Fig. 3.5b). During 
the late stages of infection in the 500 CFU model, moribund TLR2-deficient animals 
developed chronic pneumonia and extensive pleuritis (Fig. 3.6h). The elevated numbers 
of bacilli in the lungs of TLR2-defic ient mice at this stage of infection was attributed to 
decreased pulmonary macrophage activation. To show that pulmonary macrophages were 
indeed less activated in TLR2-deficient animals, iNOS immunostaining was performed 
on lungs sections of chronically infected animals (Fig. 3.7). 
Figure 3.7 Diffused iNOS expression in the lungs of M. tuberculosis infected TLR2-deflcient mice. 
Immunohistochemical staining was performed on lung sections of wild-type and TLR2-deficient mice 
infected with 500 CFU M. tuberculosis. Lungs were removed at 98 days post-infection and stained using a 
polyclonal rabbit anti-mouse antibody (see Materials and methods). Brown staining shows iNOS-positive 















Pulmonary macrophages present In wild-type lungs expressed iNOS within the 
granuloma structure (Fig. 3.7a), and although TLR2-deficient macrophages also 
expressed iNOS, these macrophages were dispersed throughout the tissue (Fig. 3.7b). In 
addition to iNOS staining, levels of nitric oxide (NO) in lung tissue homogenates were 
lower in TLR2-deficient mice during the chronic stages of infection (Table 3.1), 
indicating that the capacity to kill mycobacteria was reduced in the absence of TLR2. 
TABLE 3.1. 






433.3 ± 44.6 
491.1 ± 43.1 
303.1 ± 96.7 
273.8 ± 14.8b 
a Total pulmonary nitrites in the lungs of wild-type and TLR2-deficient mice infected with 500 CFU M 
tuberculosis. Total pUlmonary nitrate was reduced by nitrite reductase to nitrite and measured by the Greiss 
reagent. 
b p<O.OO1 
Therefore, the decreased levels of NO present in lung homogenates of TLR2-deficient 
mice indicated that activation of macrophages in response to tubercle bacilli was 
dependent on TLR2. 
3.2.5 Macrophages require TLR2 to respond optimally to M. tuberculosis bacilli 
Stimulation of macrophages with mycobacterial bacilli induces the production of TNF 
and IL-12p40, both of which have important roles in the control of local immune 
responses against M tuberculosis (Flynn et al., 1995; Holscher et aI., 2001). In this 
regard, we sought to determine whether TLR2 was required by macrophages to respond 
optimally to live mycobacteria. Here, peritoneal macrophages from wild-type and TLR2-
deficient mice were stimulated with either LPS or live M tuberculosis bacilli (Fig. 3.8). 
Indeed, macrophages deficient in TLR2 produced significantly less TNF (Fig. 3.8a) and 
IL-12p40 (Fig. 3.8b) than wild-type controls, while no significant difference was 
observed between the two groups when stimulated with LPS. The results therefore imply 
that the decreased NO levels in the lungs of TLR2-deficient mice could be due to 











defective macrophage response in vitro in terms of TNF and IL-12p40 production, a 
result which would indicate that the pulmonary inflammatory response in TLR2-deficient 
mice would also be reduced. 
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Figure 3.8 Reduced cytokine production on TLR2-deficient macro phages with an in vivo phenotype. 
Elicited peritoneal macrophages from wild-type (.) and TLR2-deficient mice (0) were incubated with LPS 
(100 nglml) or live M tuberculosis (MOl = 2: 1). Supernatants were harvested 4 hours after stimulation and 
assayed for 1NF (a) and lL-12p40 (b) by ELISA. *,p < 0.01; **,p < 0.001. 
3.2.6 Analysis o/pulmonary immune responses in TLR2-deficient mice 
Macroscopically, the lungs ofTLR2-deficient mice became swollen and larger than wild-
type controls at days 56 and 98 post-infection (Fig. 3.9a), weighing significantly more 
than control mice at these time points. The increase in lung mass at day 56 post-infection 
corresponded with the development of lung pathology in TLR2-deficient animals at the 
same time point (Fig. 3.6f). The inflammatory lung pathology was not a result of lower 
pro inflammatory cytokines but was associated with increased amounts of both TNF and 
IL-12p40 in lung homogenates of TLR2-deficient animals. Here, the levels of TNF in 
lung homogenates of TLR2-deficient animals were initially higher at 4 weeks post-
infection (Fig. 3.9b), and remained so for the duration ?f infection. Levels of IL-12p40 
were also elevated in TLR2-deficient animals, however significant differences between 
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Figure 3.9 Increased lung weight and inflammatory cytokine production in TLR2-dejicient mice infected 
with M. tuberculosis. Wild-type (_) and TLR2-deficient mice (0) were infected aerogenic ally with 500 
CFU M tuberculosis. Animals were sacrificed at days 14,28,56 and 98 post-infection, following which 
lung weights (a), TNF (b), IL-12p40 (c), and IFN-y (d) in lung homogenates were recorded. *,p < 0.01; 
**,p < O.OOL 
In addition to elevated levels of TNF and IL-12p40 in lung homogenates of TLR2-
deficient mice, levels ofIFN-y present in the lungs of these animals remained higher than 
those observed in wild-type controls at days 14, 28 and 56 post-infection (Fig. 3.9d). 
Production oflFN-y is a key effector mechanism against M tuberculosis and is mediated 
by T cells at the site of infection. To determine whether the elevated levels of IFN-y 
present in the lungs of TLR2-deficient mice could be correlated with an increase in the 
amount of infiltrating T cells, flow-cytometric analysis of the recruitment of lymphocytes 
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Figure 3.10 Increased recruitment and activation of T cells in TLR2-deficient mice infected with M. 
tuberculosis. Wild-type (_) and TLR2-deficient mice (0) were infected with aerogenically with 500 CFU 
M tuberculosis. Lung cells were harvested 2, 4 and 8 weeks post-infection and stained for CD3, CD4, 
CD8, CDlla and CD44. (a & b) Percentages ofCD3+ CD4"'" and CD3"'" CDS"'" cells in lymphocyte gate from 
wild-type and TLR2-deficient animals. (c-j) Percentages of activated CD4+ and CDS+ cells in the 











Higher numbers of CD4+ and CD8+ T cells were present in the lungs of TLR2-deficient 
animals after 3 weeks of infection (Fig. 3.l0a & b). These cells also showed increased 
expression of the activation markers CDlla and CD44 at weeks 4 and 8 post-infection 
(Fig. 3.10c-t), indicating that the elevated levels of IFN-y found in the lungs of TLR2-
deficient mice was associated with increased recruitment and activation of both CD4+ and 
CD8+ T cell populations. To determine whether the elevated levels of IFN-y present in 
the lungs of TLR2-deficient were due to the increased activation of the lymphocyte 
compartment, in vitro Ag-specific restimulation assays were performed. 
3.2.7 Antigen-specific T cell responses in TLR2-deficient mice infected with M. 
tuberculosis. 
Recall responses of Ag-specific T cells are optimal during the third and fourth week of 
infection, after which these responses decline. Animals aerogenically infected with 500 
CFU M tuberculosis were therefore sacrificed at 4 weeks post-infection, following which 
spleens were removed. Restimulation of wild-type and TLR2-deficient splenocytes with 
either ConA or mycobacterial bacilli (Fig. 3.lla), showed higher levels of IFN-y 
produced by TLR2-deficient cell cultures. This was observed for the Ag-specific bacillus 
stimulus as well as the non-specific mitogen ConA. To determine whether the increased 
IFN-y levels observed in TLR2-deficient splenocyte cultures was a result of increased T 
cell numbers, enriched T cell uspensions were prepared from infected mice and 
restimulated in vitro (Fig. 3.l1b). Here, enriched CD3+ T cell suspensions were prepared 
from wild-type mediastinal lymph nodes on day 28 after infection with M tuberculosis 
by magnetic cell sorting. Enriched CD3+ T cells with a purity of >95% were restimulated 
in vitro with Ag-pulsed wild-type or TLR2-deficient peritoneal macrophages, and IFN-y 
production was measured (Fig. 3.11 b). In the case of TLR2-deficient peritoneal 
macrophages pulsed with either PPD or viable M tuberculosis, the resulting 
restimulation of wild-type enriched CD3+ T cells produced more IFN-y than T cells 
restimulated by wild-type macrophages. This would indicate that TLR2 signaling might 
influence the outcome of either CD4+ or CD8+ T cell differentiation. Indeed, down-
regulation of cell surface molecules such as MHC-II by M tuberculosis might be a 













implicated TLR2 in the inhibition of macrophage MHC-II expression by 19-kDa 
lipoprotein from M tuberculosis (Noss et al., 2001; Tobian et al., 2003; Pai et al., 2003; 
Ramachandra et al., 2001). Thus, increased levels of IFN-y present in TLR2-deficient 
restimulation assays may be partly due to skewed antigen presentation. In the case of 
TLR2-deficient animals infected with 500 CFU M tuberculosis, elevated levels ofIFN-y 
present in lung homogenates at 2 weeks post-infection (Fig. 3.9d), could not be correlated 
with increased numbers ofCD4+ T cells (Fig. 3. lOa). Analysis of pulmonary CDl1c + and 
Ly-6G+ cells present in the lungs of TLR2-deficient animals at 2 weeks post-infection 
showed that although there were no differences in the numbers of cells present (Fig. 
3.11a), cell surface expression ofMHC-II was higher in animals deficient in TLR2 when 
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Figure 3.11 Ag-specific IFN-y production and MHC-1J cell-surface expression is elevated in TLR2-
deficient animals. (a) Splenocyte restimulation assay from 4 week-infected wild-type (_) and TLR2-
deficient mice (0)_ (b) Ag7specific stimulation of CD3+ T cells from pooled mediastinal lymph nodes of 4 
mice 28 days after infection. (c-d) Cell-surface analysis ofMHC-II expression on pUlmonary CDllc+ and 
Ly-6G+ cells in wild-type and TLR2-deficient mice at 2 weeks post-infection. One representative of two 












Microbial ligands have been shown to activate various mammalian TLRs, facilitating the 
transcription of genes that activate the adaptive immune response, including cytokines 
and various co-stimulatory molecules (Takeda et al., 2003; Underhill et al., 1999b; 
Takeuchi et al., 1999; Brightbill et aI., 1999; Stenger et al., 2002). Globally, animals 
deficient in the adaptor protein MyD88 have been used as a tool to evaluate the 
importance of TLR-signaling in the initiation of an innate immune response. In the 
context of a virulent M tuberculosis infection, the absence MyD88 results in an increased 
systemic mycobacterial infection which ultimately results in the host succumbing to the 
disease before congenic wild-type controls (Fig. 3.1). Collectively, this result has been 
confirmed by other groups investigating the in vivo contribution ofMyD88 towards an M 
tuberculosis infection (Scanga et al., 2004; Fremond et al., 2004; Sugawara et ai., 2003), 
although the models used do differ individually. Results presented by Scanga et al. 
(2004) and Sugawara et al. (2003) reveal that the infectious dose, strain of M 
tuberculosis used, and genetic background of gene-deficient animals largely affect the 
experimental outcome. However, the results presented by Sugawara et al. (2003) 
suggested that the development of an adaptive immune response during an M 
tuberculosis infection was not entirely dependent on the presence of MyD88. This 
concept was proven by Fremond et al. (2004) in which vaccination with Mycobacterium 
bovis bacillus Calmette-Guerin (BCG) conferred substantial protection to a virulent M 
tuberculosis infection despite the absence ofMyD88. The authors concluded that MyD88 
is an essential component of an innate immune response against M tuberculoSis, but that 
the development of adaptive immunity can proceed in its absence. 
Although the role of MyD88 in innate immunity following an M tuberculosis 
infection is largely associated with TLR-signaling, a role for IL-l and IL-18 signaling 
during infection should not be ignored. In this regard, both IL-l and IL-18 signal via 
MyD88 (Adachi et aI., 1998) and in their absence, could partially account for the 
susceptibility of MyD88-deficient mice towards mycobacterial infections (Juffermans et 
al., 2000; Yamada et al., 2000). Nevertheless, within the repertoire of ligands recognized 













mycobacterial antigens (Thoma-Uszynski et ai., 2001; Bulut et ai., 2001; Takeuchi et ai., 
2002). Within this group of TLRs, TLR2 appears to have a more dominant role in that 
agonists of this receptor have been identified to be whole mycobacteria, mycobacterial 
cell wall glycolipid lipoarabinomannan (LAM), mannosylated phosphatidylinositol, and a 
19-kDa Mtb lipoprotein (Thoma-Uszynski et ai., 2001; Aliprantis et ai., 1999; Underhill 
et ai., 1999b; Gilleron et al., 2003; Quesniaux et al., 2004~. More specifically, in vitro 
experiments have confirmed that TLR2 activation is directly linked to killing of 
mycobacterial bacilli (Thoma-Uszynski et ai., 2001), an event that corresponds with 
increased NO production by murine macrophages, and that live mycobacterial bacilli 
induce TNF and IL-12p40 production in a TLR2-dependent manner (Fig. 3.8). 
Extrapolation of these findings into an in vivo model would suggest that animals lacking 
TLR2 would be more susceptible to a mycobacterial infection. Results presented here 
would argue that TLR2 is indeed required for optimal control of a virulent aerogenic M 
tubercuiosis infection. In an animal lacking TLR2, disease progression is associated with 
elevated mycobacterial numbers in the lungs as well as increased dissemination of bacilli 
into both the spleen and liver (Fig. 3.2 & 3.4). Furthermore, these animals are unable to 
form mycobactericidal granulomas (Fig. 3.5 & 3.6), and succumb to the infection before 
wild-type controls (Fig. 3.4). 
Comparison of these results with other models investigating the in vivo role of 
TLR2 during mycobacterial infections indicates that TLR2-signaling is not redundant 
during disease progression. In an acute model of M bovis BCG infection, intraperitoneal 
challenge with BCG resulted in a tenfold higher bacterial load in the lungs of TLR2-
deficient mice (Heldwein et ai., 2003). In models using an aerogenic route of infection, 
TLR2-deficient mice infected with the Kurono strain of M tuberculosis displayed a 
reduced capacity to control the pulmonary infection (Sugawara et ai., 2003), while in a 
high-dose infection model using M tubercuiosis H37Rv, TLR2-deficient mice were more 
susceptible than wild-type controls (Reiling et ai., 2002). Differences in these models can 
be ascribed to the initial route of infection, the strain of M tuberculosis used (Dormans et 
al., 2004; Lopez et ai., 2003; Manabe et ai., 2003), and the genetic background of 
animals used in experiments (Pan et al., 2005; Mitsos et ai., 2000; Kamath et al., 2003) 
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however, the general conclusion is that TLR2 has a more prominent role during an M 
tuberculosis infection than TLRs 4 or 6. 
The results presented by Reiling et al. (2002) more closely reflect the results 
presented in this chapter. Animals deficient in CDI4, TLR2 or TLR4 control a low-dose 
aerogenic M tuberculosis infection at 15 weeks post-infection, although a TLR2-
deficiency results in an increased systemic infection and poor granuloma formation by 22 
weeks post-infection (Fig. 3.2 & 3.5). In a high dose M tuberculosis infection model, 
animals deficient in TLR2 succumb to the disease before wild-type controls (Reiling et 
al., 2002; Fig. 3.4), mortality being associated with an increased systemic infection (Fig. 
2.4) and chronic pneumonia (Fig. 3.6). Histologically, the lungs of TLR2-deficient 
animals showed accelerated tissue pathology associated with elevated levels of 
pro inflammatory cytokines (Fig. 3.9), causing extensive pulmonary inflammation. The 
elevated levels of proinflammatory cytokines present in the lungs of TLR2-deficient mice 
may however be the consequence of an inability of the host to control replication of the 
bacillus at the level of the macrophage. Here, production of TNF, IL-12p40 and NO by 
macrophages is dependent on TLR2 signaling (Fig. 3.8; Reiling et al., 2002; Thoma-
Uszynski et al., 2001). The resulting NO produced by the macrophage is then required by 
the cell to kill intracellular bacilli, a process which is mediated by TLR2 (Thoma-
Uszynski et al., 2001). The reduced expression of iNOS in the lungs of TLR2-deficient 
animals (Fig. 3.7) along with lower levels of pulmonary NO (Table 3.1) suggest that 
pulmonary macrophages produce less related nitrogen intermediates than wild-type 
controls and would therefore contain more mycobacterial bacilli (Fig. 3.4a). The 
increased recruitment of activated CD4+ and CD8+ T cells to the lungs of TLR2-deficient 
animals could be a result of the host attempting to compensate for the decreased effector 
functions of TLR2-deficient macrophages. Indeed, it has been shown that the addition of 
TNF and IFN-y to macrophage cell cultures effects killing of intracellular mycobacteria 
to the same extent as 19-kDa-induced TLR2-mediated activation (Thoma-Uszynski et al., 
2001), indicating that TNF, IFN-y and at least TLR2 work in concert to kill intracellular 
mycobacterial bacilli. However, in the absence of TLR2, increased amounts of TNF and 















levels of pulmonary NO and increased bacillary burden present in TLR2-deficient mice 
(Table 3.1; Fig. 3.4). 
An increased proinflammatory response has however been shown to be 
detrimental for the host. Here, high levels of TNF have been associated with cachexia and 
septic shock (Beutler et al., 1988) and high-dose therapy using IL-12 has been shown to 
have toxic inflammatory side effects (Ryffel et al., 1997). In the M tuberculosis model, 
TNF has been associated with host-mediated destruction of lung tissue (Rook et al., 
1989; Moreira et aI., 2002), the increased lung pathology correlating with elevated levels 
of pulmonary TNF. In a recent report a role for IL-27 was described in limiting the 
pathological sequelae of chronic inflammation induced by an aerogenic M tuberculosis 
infection (Holscher et al., 2005). In this study, the absence of IL-27 /WSX -1 resulted in 
increased production of the pro inflammatory cytokines TN"F and IL-12p40 as we]] as an 
increased pulmonary recruitment of activated CD4+ T cells. The higher levels of 
protective immunity were however associated with a chronic inflammatory response 
which subsequently resulted in the accelerated death of WSX -I-deficient mice. 
Histologically, the lungs of these animals showed advanced inflammatory cell infiltration 
and interstitial fibrosis, an accelerated lung pathology that was associated with increased 
levels ofTNF and IL-12p40. These animals also exhibited increased Ag-specific CD4+ 
T -cel1 responses towards M tuberculosis which accompanied increased macrophage 
effector functions such as NOS2-dependent reactive nitrogen intermediates. In TLR2-
deficient animals an increased Ag-specific T-ce]] response was also mounted (Fig. 3.11), 
which was unable to compensate for the defective macrophage effector functions due to 
the absence of TLR2. It remains to be determined whether the increased expression of 
MHC-IJ on pulmonary CDllc+ and Ly-6G+ could account for the elevated Ag-specific T-
cell responses (Fig. 3.11), particularly due to the fact that mycobacterial bacilli are able to 
regulate MHC-II Ag-processing via TLR2 (Noss et al., 2001 & 2002). The regulation of 
MHC-II expression is not only restricted to the receptor itself, but extends to the 
induction of mRNA for class II transactivator (CIITA), IFN regulatory factor-I (lRF-l), 
and MHC-II by IFN-y (Pai et al., 2003). Here, M tuberculosis 19-kDa lipoprotein 
directly inhibits IFN-y-induced MHC-IJ expression, thereby linking TLR2 activation to 
















responses towards M tuberculosis antigens, but is also involved in counterregulatory or 
inhibitory processes such as inhibition of MHC-II expression. 
Apart from TLRs 1, 2, 4 and 6, several other receptors have been shown to 
mediate interactions of M tuberculosis with macrophages. Receptors found to participate 
in phagocytosis of M tuberculosis by macrophages include CDI4, complement 
receptors, scavenger receptors, mannose receptor, dendritic cell-specific ICAM-3-
grabbing nonintegrin (DC-SIGN), CD44, and Fcy receptors (Ernst et aI., 1998; Leemans 
et al., 2003). M tuberculosis induces the production of reactive nitrogen intermediates 
and matrix metalloproteinase-9 upon engagement of mannose receptor (Rivera-Marrero 
et al., 2002; Ezekowitz et al., 1990). CD14 has been implicated in the uptake of 
nonopsonized tubercle bacilli as well as the LAM-stimulated release of TNF, IL-l, and 
IL-8 (Peterson et al., 1995; Zhang et al., 1993; Pugin et aI., 1994). DC-SIGN has been 
shown to mediate the uptake of tubercle bacilli by human monocyte-derived dendritic 
cells (Tailleux et al., 2003; Geijtenbeek et al., 2003), and has been implicated in 
transmitting M tuberculosis-induced signals in dendritic cells and macrophages 
(Geijtenbeek et al., 2003; van Lent et al., 2003). There are therefore several cell-surface 
receptors other than those belonging to the TLR protein family that are involved in 
mediating macrophage responses towards M tuberculosis. The balance between the use 
of these cell-surface receptors as a means to activate a proinflammatory innate immune 
response and potential mechanisms used by the bacillus to evade that response ultimately 
results in either protective immunity or chronic disease. Studies using individual PRR-
deficient animals should therefore take into account the fact that much redundancy exists 
within recognition of mycobacterial components, and pronounced phenotypes in such 
models can depend on several factors. Although genetic background and strain of M. 
tuberculosis used can influence the experimental outcome, results presented here indicate 
that TLR2 plays a more prominent role during an M tuberculosis infection than either 
CD14 or TLR4. 
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Trypanosoma bruce; as a model for innate immunity 
Summary 
The initial host response towards the extracellular parasite Trypanosoma brucei is 
characterized by the early release of inflammatory mediators associated with a Type 1 
immune response. In this chapter, results argue that this inflammatory response is 
dependent on activation of the innate immune system mediated by the adaptor molecule 
MyD88. Here, MyD88-deficient macrophages are non-responsive towards both soluble 
variant-specific surface glycoprotein (sVSG) as well as membrane bound VSG (mNSG) 
purified from T. brucei. Infection of MyD88-deficient mice with either clonal or non-
clonal stocks of T. brucei resulted in elevated lev ls of parasitemia. This was 
accompanied by reduced plasma IFN-gamma and TII..l"F levels during the initial stage of 
infection, followed by moderately lower VSG-specific IgG2a antibody titers during the 
chronic stages of infection. Analysis of several TLR-deficient mice revealed a partial 
requirement for TLR9 in the production of IFN-y and VSG-specific IgG2a antibody 
levels during T. brucei infections. The My D88-dependent induction of an inflammatory 
response was also associated with infection-induced pathology in that animals lacking 
MyD88 were less anemic than wild-type controls. These results implicate the mammalian 
TLR family and My D88 signaling in the innate immune recognition of T. brucei as well 












To date, several reports have investigated the role of TLRs in initiating an innate immune 
response against experimental parasitic infections including T. cruzi, L. major, P. berghei 
and T. gondii (Campos et al., 2004; Debus et al., 2003; Adachi et al., 2001; Scanga et aI., 
2002). Collectively, the MyD88-dependent production of inflammatory cytokines was 
shown in vitro as well as in vivo, thereby implicating the TLR protein family in the initial 
recognition event. More specifically, in vitro experiments using APC deficient in MyD88 
showed that the adaptor molecule was required for the initial induction of IL-12 
following stimulation with parasite antigen (Scanga et ai., 2002; Campos et aI., 2004), 
while animals deficient in MyD88 were more susceptible to live infections when 
compared to wild-type controls (Muraille et al., 2003; Adachi et al., 2001). The majority 
of these models therefore indicated that the induction of inflammatory cytokines required 
the MyD88-dependent activation of an innate immune response, the absence of which 
resulted in susceptibility towards parasitic infection. 
The induction of an early polarized variant surface glycoprotein (VSG)-specific 
Type 1 immune response following an African trypanosome infection is generally 
associated with overall host resistance (Schleifer et al., 1993; Mansfield, 1994; Schopf et 
al., 1998; Magez et al., 2002). More specifically, control of a T. brucei infection at the 
level of parasitemia has been associated with the early induction of Type I cytokines such 
as TNF and IFN-y, as well as a VSG-specific B cell response (Cross et al., 1990; Borst et 
ai., 1994; Hertz et al., 1998; Magez et ai., 1999). At the level of the macrophage, the 
production of TNF is the result of the combined activation by circulating s VSG released 
by the parasite due to stress, as well as membrane-bound VSG (mfVSG) that consists of 
the dimyristoylglycerol (DMG) lipid moiety of the glycosylphosphatidylinositol (GPI) 
anchor (Ferguson et al., 1988; Magez et al., 1998). Individually, while sVSG induces 
macrophages to secrete TNF in an IFN-y-dependent manner, mfVSG can overactivate 
macrophages in an IFN-y-independent manner (Magez et al., 1998). The induction of 
both TNF and IFN-y are therefore critical cytokines required for the initial control of the 
disease, their absence being associated with a severely diminished capacity to control 













TNF due to an infection is however also believed to be related to the severity of T 
brucei-induced pathology (Magez et al., 2002). Here, TNF-induced pathology has been 
associated with anemia and inflammation of the brain in both the human and animal host 
(Okomo-Assoumou et al., 1995; Lucas et al., 1993; Magez et al., 2002). 
The requirement for MyD88 in mediating cellular inflammatory responses 
towards various parasitic antigens indicated that macrophage activation and TNF 
production by T brucei sVSG and mfVSG was dependent on MyD88-signaling. Results 
presented here show that T bruce i-derived sVSG and mfVSG do indeed activate 
macrophages in a MyD88-dependent manner, and mice lacking the adaptor are unable to 
control either clonal or non-clonal T brucei infections. Dissection of this response 
indicated that macrophages required TLR9 to respond to T bruce i-derived genomic 
DNA, while TLR9 was found to partially mediate immune inflammatory responses 
during the later stages of infection. Although MyD88 is required by the host to 
effectively control a T brucei infection, activation of an inflammatory response via this 
adaptor protein was also associated with infection-induced anemia. Thus, while the host 
requires My D88 to control the development of parasitemia, this event is also responsible 













4.2.1 Macrophages require MyD88 to respond optimally to sVSG and mjVSG 
It has previously been shown that the glycosylinositolphosphate (GIP) moiety of sVSG is 
the main trypanosome-derived TNF-inducing component (Magez et aZ., 1998). However, 
the TNF-inducing capacity of sVSG required IFN-y priming, suggesting that in an in vivo 
setting, macrophage responsiveness towards sVSG occurs after an IFN-y pre stimulation 
event. Here, all s VSG macrophage stimulation experiments were performed using a 
concentration of protein no higher than 10 Ilg/ml, a dose corresponding to a trypanosome 
load of approximately 2x107 parasites during infection. To determine whether 
macrophage TNF responses towards sVSG might be mediated by TLRs, bone marrow-
derived macrophages deficient in the adaptor molecule MyD88 were stimulated with 
sVSG either in the presence or absence of IFN-y (Fig. 4.1 a). Neither wild-type nor 
MyD88-deficient macrophages responded to sVSG in the absence of IFN-y. Upon 
pre stimulation with IFN-y, wild-type macrophages produced TNF in a dose-dependent 
manner while macrophages deficient in My D88 produced none. TNF production in 
response to LPS was reduced in MyD88-deficient macrophages (Fig. 4.1 a), but not 
absent. sVSG fractions were free of endotoxin, indicating that TNF production was solely 
due to sVSG stimulation. The produc ion of nitrite by wild-type macrophages in response 
to s VSG was dependent on IFN-y priming, but was reduced in MyD88-deficient 
macrophages (Fig. 4.lb). In contrast to TNF and nitrite, no IL-6 or IL-12p40 were 
detected in culture supernatants (Fig. 4.lc & d), and pre stimulation with IFN-y did not 
induce macrophages to secrete IL-6 or IL-12p40 in response to sVSG. In general, 
macrophages were far less responsive towards sVSG than they were to LPS (Fig. 4.1a-d). 
Here, cytokine production induced by } Ilg/ml LPS far exceeded that produced by 10 
Ilg/ml sVSG. 
In response to environmental stress, trypanosomes release their VSG via a VSG 
lipase (Rolin et aI., 1996). Once this occurs, the dimyristoylglycerol (DMG) VSG anchor 
remains in the trypanosoma} membrane while the GIP-VSG is released (Fox et aZ., 1986). 
However, during a trypanosoma] infection, it is also likely that macrophages are exposed 
to the VSG-GPI anchor due to lyses of trypanosomes. 
60 
,
' : rn J HU,-,,-,'''V'l.
IS
















































" c c 




..q~ .,; c " " 
























~ ~ "<i c 
















































c ] I~ ~ -.:i " c 


















-.:i -.:i -.:i -.:i -.:i -.:i c c c c c C 
-0 '" 5 10 "0 '" 5 10 ~ a.. " "-..J :;;: ..J 
sV3J sV3J 
(og/ml) (1lSIml) 
·IFNy + IFNy 
~ n ~ "<i -.:i c " 









Figure 4.1 Impaired responses to T. brucei antigen in MyD88/- macro phages. (a-d) Bone marrow derived 
macrophages from wild-type (filled bars) or MyD88-/' (open bars) mice were stimulated with LPS (I Jlg/mJ) 
or AnTat1.l T. brucei soluble VSG (5 or IOJlglml) in the presence or absence of 30 U/mlIFN-y for 24h. 
TNF, Nitrite, IL-6 and IL-12p40 in culture supernatants were determined by ELISA. (e-h) Bone marrow 
derived macrophages from wild-type and MyD88-/- mice were stimulated with LPS (I Jlglml) or AnTatl.l 
T. brucei membrane-fraction VSG (5 or 10Jlglml) in the presence or absence of 30 U/ml IFN-y for 24h. 
Concentrations of TNF, Nitrite, IL-6 and IL-12p40 in culture supernatants were determined by ELISA. 











Within this context, it has already been shown that mNSG can elicit a macrophage 
response and that this response is independent of IFN-y prestimulation (Magez et al., 
1998). To determine whether mNSG-induced macrophage responsiveness was 
dependent on MyD88 signaling, macrophages deficient in MyD88 were stimulated with 
mNSG either in the absence or presence of IFN-y (Fig. 4.le-h). Firstly, macrophages 
required MyD88 to produce TNF in response to mNSG stimulation (Fig. 4.le), but in 
contrast to sVSG, this response was not dependent on prestimulation with IFN-y. 
Secondly, macrophages did require MyD88 and IFN-y pre stimulation to produce nitrite 
upon mNSG stimulation (Fig. 4.lf). Thirdly, unlike macrophages stimulated with sVSG 
(Fig. 4.1c & d), macrophages stimulated with mNSG secreted both IL-6 and IL-12p40 
(Fig. 4.lg & h), the production of which was not dependent on IFN-y prestimulation. 
However, while MyD88 was required by macrophages to produce IL-6 in response to 
mNSG stimulation (Fig. 4.1g), the production of IL-12p40 was MyD88-independent 
(Fig. 4.lh). Therefore, macrophages in general were far more responsive towards mNSG 
than sVSG, the response required MyD88 for the production ofTNF, IL-6 and nitrite but 
not IL-12p40. 
4.2.2 Mice require MyD88 signaling to control aT. brucei infection 
To evaluate the role of MyD88 in host resistance to T brucei, mice deficient in MyD88 
were infected with clonal pleiomorphic AnTatl.1 T. brucei. The development of 
parasitemia and survival of th se animals were compared to wild-type controls, as well as 
mice deficient in either IFN-yRl or TNF (Fig. 4.2). In terms of development of 
parasitemia, mice deficient in MyD88 could not efficiently control the height of first peak 
parasitemia, a phenotype similar to mice deficient in either IFN-yRl or TNF (Fig. 4.2a & 
c). Following clearance of the first peak of parasitemia, wild-type animals developed a 
reduced second peak of parasitemia at days 13-15 post-infection, and succumbed to the 
final lethal peak of parasitemia at approximately 40-50 days post-infection (Fig. 4.2a). 
Animals deficient in either MyD88 or IFN-yRI had significantly elevated parasitemia 
levels post first-peak (Fig. 4.2a), which remained elevated for the duration of the 
infection with both gene-deficient animals succumbing to infection before wild-type 

















parasitemia development post first-peak: more effectively than either MyD88- or IFN-
yRI-deficient animals (Fig. 4.2c), and displayed similar survival kinetics when compared 
to wild-type controls (Fig. 4.2d; p > 0.10). Thus, MyD88-deficient animals succumbed to 
the infection before TNF-deficient animals (Fig. 4.2d;p < 0.0 I). 
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Figure 4.2 MyD88 is required to control a pleomorphic T. brucei AnTatl.i infection_ Parasitemia 
development and survival in (a-b) wild-type (_), MyD88-1- (0), IFN-yRr'- (0) and (c-d) wild-type (_), 
MyD88-1- (0), and TNF+ (0) mice. Five mice per group were infected at day 0 intraperitoneally with 5x103 
AnTatl.l T. brucei parasites. Parasitemia data indicate mean ± of 5 mice per group, while survival data is 











In addition, IL-12p40 did not contribute significantly to first-peak parasitemia control as 
animals deficient in this cytokine controlled the first peak of parasitemia as wen as wild-
type controls (Table 4.1). To determine whether the impaired resistance of MyD88-
deficient mice towards a T. brucei infection could be attributed to a reduced Type 1 
immune response, IFN-y and TNF were measured in the plasma at various time-points 
post-infection (Fig. 4.3a & b). At 4 days post-infection, MyD88-deficient mice had 
reduced plasma IFN-y levels when compared to wild-type controls (Fig. 4.3a), which then 
increased marginally at day 6 post-infection. A similar trend was observed for plasma 
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Figure 4.3 MyD88 is required to mount an early inflammatory response following a T. brucei infection. (a-
b) wild-type (filled bars), MyD88-1. (open bars), and TNF/- (striped bars) were infected intraperitoneally 
with 5x103 AnTatl.l T brucei parasites. Sera was collected at days 4 and 6 post-infection and analysed for 
IFN-y and TNF by ELISA. n.d., not detected. (c-e) Sera was collected from wild-type (.), MyD88-1- (0) and 
TNF'- (0) mice at days 4, 6 and 20 post-infection and analysed for VSG-specific IgM and IgG2a 
antibodies. 
For comparative purposes, plasma IFN-y levels were analyzed in TNF-deficient animals. 











infection (Fig. 4.3a). Furthermore, parasite cJearance is also mediated by a VSG-specific 
Ab response. Here, VSG-specific IgM and IgG2a titers at days 4, 6 and 20 post-infection 
were moderately reduced in MyD88-deficient animals (Fig. 4.3d, e & f). Antibody titers 
for IgGl, IgG2b and IgG3 in MyD88-and TNF-deficient mice were comparable to wild-
type controls for the duration of infection (data not shown). Thus, the development of a 
Type 1 cytokine and VSG-specific IgG2a response during a cJonal T brucei infection is 
mediated in part by the MyD88-dependent activation of the innate immune system. 
4.2.3 T. brucei induces immunopathology by MyD88-dependent mechanisms 
The induction ofTNF by T bruce i-derived sVSG and mfVSG is an important component 
of parasitemia control and host survival (Magez et al., 1998; Magez et al., 1999), but is 
also largely responsible for infection-associated immunopathology such as anemia 
(Magez et a/., 2002; Magez et al., 2004). The development of anemia in laboratory mice 
following an experimental T brucei infection has been shown to be largely mediated by 
TNF (Magez et ai., 2004), the production of this cytokine being a consequence of 
macrophage activation by parasite-derived glycoproteins and GPI moieties. Results 
presented here show that the induction of TNF following stimulation of macrophages 
with sVSG or mfVSG is MyD88-dependent (Fig. 4.1), and that animals deficient in 
MyD88 have lower systemic TNF levels during the first peak of infection than those 
observed for wild-type controls (Fig. 4.3b). The development of anemia was therefore 
assessed in animals lacking MyD88 to determine whether the adaptor molecule had a role 
to play in infection-associated pathology. Wild-type animals infected with pleiomorphic 
AnTatl.l T brucei become progressively more anemic during the chronic stages of 
infection (Fig. 4.4), with animals losing on average 47% of red blood cells compared to 
the first day of infection. Infection of animals deficient in TNF were considerably more 
resistant to the development of anemia (Fig. 4.4a), and only lost 13% of red blood cells 
following cJearance of the first peak of parasitemia. Similarly, animals lacking MyD88 
(Fig. 4.4b) or IFN-yRl (Fig. 4.4c) are also more resistant to infection-associated anemia, 
losing 17% and 15% of red blood cells during infection respectively. Therefore, the 
MyD88-dependent activation of an innate immune response following infection with T 
brucei results in the production of TNF and IFN-y (Fig. 4.3a & b), both of which 
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contribute to the control of parasitemia and development of anemia in wild-type C57BII6 
animals. Collectively, the MyD88-dependent induction of a Type 1 inflammatory 
response following a T. brucei infection suggests a role for TLRs in the initial activation 
of this innate immune response. 
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Figure 4.4 Development of anemia following a pleomorphic T. brucei AnTatl.l infection is MyD88-
dependent. Anemia expressed as numbers of red blood cells/ml blood in (a) wild-type (_), and lNF/- (0) 
mice; (b) wild-type (_), and MyD88-1- (0) mice; and (c) wild-type (_), and IFN-yRrl- (o) mice. Five mice 
per group were infected at day 0 intraperitoneally with 5x 103 AnTat1.l T. brucei parasites. 
4.2.4 Analyses of several TLR-dejicient mice reveal a role for TLR9 in T. brucei 
parasitemia control 
Although MyD88 is an integral component of the TLR-signaling pathway (Kaisho et al., 
2001), the role this adaptor molecule has in conferring responsiveness towards IL-l and 
IL-18 should be addressed in infectious models (Medzhitov et al., 1998; Wesche et al., 











deficient animals during a clonal T. brucei infection was associated with defective IL-l 
and/or IL-18 signaling, mice deficient in IL-l Rl and caspase-l were infected with clonal 
T. brucei. In contrast to MyD88-deficient mice, these mice controlled the first and second 
peaks of parasitemia as well as wild-type controls (Table 4.1), indicating that the 
increased susceptibility towards T. brucei observed for MyD88-deficient animals was due 
to defective TLR-signaling. Here, screening of several PRRfTLR-deficient animals 
revealed that neither CD14, TLRI, TLR2, the combination of both TLR2 and 4, nor 
TLR9 were required by the host to control the first peak of parasitemia following a clonal 
T. brucei infection (Table 4.1). However, animals deficient in TLR9 developed elevated 
levels of parasitemia following clearance of the first peak of parasites (Table 4.1), 
indicating that TLR9 could be involved in parasitemia control post first-peak. 
TABLE 4.1 Systemic responses of PRR- and cytokine-deficient mice following a clonal T. brucei infection] 
Mouse strain 1st Peak parasitemia 2nd Peak parasitemia % RBC loss 
(x2.1 06 Par.lml) (x2.1 06 Par.lm]) 
2C57BI/6 56 ± 7 9 ± 5 47 
TLRrf - 58 ± 6 ] 0 ± 7 43 
TLR2-I- 37 ±.. 12 ± 9 44 
TLR9-1- 51 ± 14 25 ± 4 46 
MyD88-1- 167 ± 47 38 + 14 17 
TNF'- 197 +41 15 ± 13 13 
IFN-yRr/- 141 ± 38 11 1 + 83 II 
IL-IRr/- 43±10 14±8 48 
Caspase-rl - 55 ±20 7 ±2 47 
1._ . ~I!d~p~Q~-~___ _ ___ ~3 + 9 1.<> ± 1_~~~ unknown 
3TLR2/4+1+ J 35 ± 48 10 ± 5 47 
TLR2/4-f - ]21 ± 23 5 ± 4 36 
] Five wild-type and PRRlcytokine-deficient mice were infected intraperitoneal1y with 5x 103 AnTat 1.1 T. 
brucei parasites. Results are representative of 2-3 similar experiments. 
2 Gene deficient mice backcrossed onto a C57BI/6 background 5 times or more. 
3 Gene deficient mice on a 129/SvJxC57B1I6 background. 
4 Gene deficient mice on a CBAIJ background 
Bold wild-type parasitemia counts 











In terms of the progressIOn of anemia, the aforementioned gene-deficient animals 
developed severe anemia during the chronic stages of infection (Table 4.1) indicating that 
individual contributions made by these TLRs and cytokines during anemia are negligible 
compared to that seen for TNF, IFN-y and MyD88. 
4.2.5 T. brucei DNA stimulates macrophages in a TLR9-dependent manner 
Following the first wave of parasitemia, lysis of the parasite results in the release of 
several parasite components into the blood stream. Apart from s VSG and mfVSG that 
promote a macrophage response, it has been reported that DNA from T. brucei is not only 
mitogenic for B lymphocytes (Shoda et al., 2001), but induces macrophages to produce 
TNF, nitric oxide and IL-12p40 in the presence of IFN-y. Here, the extent of B cell 
proliferation and macrophage activation was associated with CG dinucleotide content, a 
feature associated with bacterial DNA and TLR9 responsiveness (Hemmi et al., 2000). It 
was therefore postulated that induction of an inflammatory response following a T. brucei 
infection might be mediated, in part, by TLR9-dependent macrophage activation. Indeed, 
when stimulated with T. brucei DNA, macrophages deficient in TLR9 produced less TNF 
(Fig. 4.5a), IL-6 (Fig. 4.5b), IL-12p40 (Fig. 4.5c) and nitrite (Fig. 4.5d) than their wild-
type counterparts. Macrophages deficient in TLR9 were unresponsive towards CpG DNA 
(Fig. 4.5a-d), but responded normally to stimulation with LPS. In general, macrophages 
were far less responsive towards T. brucei genomic DNA than they were to CpG DNA 
(Fig. 4.5a-d), possibly due to the fact that the frequency of CG dinucleotides in T. brucei 
genomic DNA is only 3.9% (Shoda et al., 2001). These results suggest that macrophage 
responsiveness towards T. brucei DNA is mediated in part by TLR9. 
4.2.6 Mice require TLR9 to control parasitemia development following first peak 
clearance 
Not only did macrophages deficient in TLR9 respond poorly to T. brucei genomic DNA, 
but animals deficient in TLR9 infected with clonal T. brucei had increased numbers of 
parasites following clearance of the first peak of parasitemia (Fig. 4.6a), although no 
significant difference was observed in the mean survival time of both wild-type and 
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Figure 4.5 Impaired responses to AnTatJ.I T. brucei genomic DNA in TLRsrl - macrophages. (a-d) Bone 
marrow derived macrophages from wild-type or 1LR9-1- mice were stimulated with CpG ODN (1.0 )lM), 
LPS (1.0 )lg/ml) or the indicated concentrations of T. brucei genomic DNA in the presence of 30 Wml IFN-
y for 24h. Concentrations TNF, IL-6, IL-12p40 and Nitrite in culture supernatants were determined by 
ELISA. n.d., not detected. 
IFN-y is a critical factor in contributing to parasitemia control following first peak 
clearance (Fig. 4.2a; Table 4.1). Analysis of plasma IFN-y levels in TLR9-deficient mice 
showed reduced IFN-y levels during the second parasitemia peak (Fig. 4.6c). Reduced 
plasma IFN-y levels coincided with clearance of the first peak of parasitemia at days 10-
13 at a point where 108 parasites would release genomic DNA into circulation. This was 
accompanied by lower VSG-specific IgG2a antibody titers at day 13 post-infection (Fig. 
4.6d), which were restored to wild-type levels by day 16 post-infection (Fig. 4.6e). The 


















'" 'E 60 '" :E '" 
~ 25 '" ::<: 40 ¢ 




i i i i ~ 
0 20 40 0 25 50 75 
Days p.i. Days p.i. 
c d e 














~ 0.2 ~ 
rl 100 0.1 "" c 0 0.0 
0.1 
0.0+-.....,--.--.,.--,.--, 
Day 13 Day]6 JO' 10' 10' 10' 10' 10' 10' JO' 10' 10' 10' 10' 
Dilution fnctor Dilution fac10r 
f 
.... 100 
<:> -as ... 







, i i i I 
0 ]0 20 30 40 50 
Days poi. 
Figure 4.6. Reduced resistance of TLRg-1- mice following a T. brucei infection. (a-b) Parasitemia 
development and survival in wild type (_) and TLR9-1- (0) mice infected intraperitoneally with 5x103 
AnTatl.l T. brucei parasites_ (c-e) Sera was collected at days 13 and 16 post-infection and analysed for 
IFN-y, VSG-specific IgG2a antibodies by ELISA. n.d., not detected. (f) Anemia development in wild-type 
(_) and TLR9..J- (0) mice and expressed as numbers of red blood cells/ml blood. 
peak of parasitemia coincided with a moderate reduction in anemia at days 10-13 post-
infection (Fig. 4.6f), although this was not significant and TLR9-deficient animals 











4.2.7 Mice require MyD88 and TLR9 to control a non-clonal T. brucei infection 
In the field, T. brucei parasites that infect livestock initially express metacyc1ic VSG and 
not the clonal form ofVSG first seen by the immune response as present on AnTatl.l T. 
brucei parasites (Magez et al., 2002; Barry et al., 1984; Graham et al., 1990). Seeing that 
the murine host required both TLR9 and MyD88 to control a clonal T. brucei infection, 
we sought to determine whether this was also true for a non-clonal metacyclic T. brucei 
infection. Using a tsetse fly as a vector, mice deficient in either TLR9 or MyD88 were 
infected with metacyclic AnTarLl T. brucei parasites (Fig. 4.7a). When compared to the 
clonal AnTatLI T. brucei infection (Fig. 4.2a & 4.6a), the non-clonal AnTarl.l T. brucei 
infection resulted in similar parasitemia profiles (Fig. 4.7a). Mice deficient in MyD88 
were unable to control both first and second parasitemia peaks. Here, non-clonal 
parasitemia levels in MyD88-deficient animals reached 4x108 parasites/ml blood at day 
20 post-infection (Fig. 4.7a), as opposed to 2xl08 parasites/ml blood for the clonal 
infection (Fig. 4.2a). Additionally, all MyD88-deficient animals succumbed to non-clonal 
infection by day 20 post-infection (Fig. 4.7b), while these animals survived for 40 days 
following a clonal infection (Fig. 4.2b). Mice deficient in TLR9 controlled the first peak 
of parasitemia as well as wild-type controls, but were unable to effectively clear parasites 
following first peak parasitemia (Fig. 4.6a). Both MyD88- and TLR9-deficient mice 
succumbed to the infection before their wild-type controls (Fig. 4.7b; p < 0.002 & p < 
0.005, respectively). In a similar set of experiments, animals lacking TNF displayed a 
profound loss in control of parasitemia (Fig. 4.7c), and succumbed to infection before 
wild-type controls (Fig. 4.7d; P < 0.005). The progression of parasitemia was also 
associated with the development of anemia (Fig. 4.7e-g), and this at a rate similar to that 
observed for non-clonal T. brucei infections (Fig. 4.4). Here, animals lacking MyD88 
showed a reduction in anemia during the first peak of infection (Fig. 4.7e), a result not 
observed in animals lacking TNF (Fig. 4.7g). The role of TNF in anemia could not be 
determined following clearance of the first peak of parasitemia as all TNF -deficient mice 
succumbed to the infection at this time-point (Fig. 4.7d & g). Clearance of the first peak 
of parasitemia coincided with moderately reduced anemia in TLR9-deficient animals 
(Fig. 4.7e & t). The results therefore demonstrate that MyD88, TNF and TLR9 contribute 












and TLR9 are partly involved in the induction of anemia both during and after the first 
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Figure 4.7. Differential requirement for MyD88, TLR9 and TNF during a non-clonal T. brucei infection. 
(a-d) Parasitemia development and survival of wild-type (_), MyD88'" (0), TLR9·1- (0) and TNF" (0) 
mice. (e-g) Anemia development in wild-type (_) and TLR9·f• (0) mice and expressed as numbers of red 
blood cells/ml blood. Five mice per group were infected with metacyclic AnTarl.l T. brucei bruce; 












There is a growing body of evidence which indicates that recognition of several parasitic 
infections leads to the MyD88-dependent activation of an innate immune response 
(Campos et ai., 2004; Debus et ai., 2003; Muraille et ai., 2003; Adachi et ai., 2001; Del 
Rio et ai., 2004; Scanga et ai., 2002). In models analyzing experimental T. gondii, T. 
cruzi, P. berghei, L. major or B. burgdorfori infections, a deficiency in MyD88 was 
correlated with reduced plasma IL-12p40 and/or IFN-y levels during the infection. This 
was accompanied by decreased production of IL-12p40 and IFN-y following splenocyte 
restimulations with parasitic antigen (Campos et ai., 2004; Muraille et ai., 2003; Adachi 
et ai., 2001; Scanga et al., 2002). Thus, in these models, the activation of the MyD88 
signaling pathway results in the early production of IFN-y and IL-12, both of which are 
essential components in host resistance against parasitic infections. 
The cytokines TNF and IFN-y have been shown to be critical factors in 
determining the relative level of host resistance against the extracellular parasite T. brucei 
(Hertz et ai., 1998; Magez et ai., 1999; Namangala et ai., 2001). Deficiencies in either of 
these cytokines have been associated with elevated levels of parasitemia and, in terms of 
IFN-y, shorter survival times. Results presented here link the initial production of TNF 
and IFN-y following a T. brucei infection to the MyD88-dependent activation of an 
innate immune response. The production of TNF by macrophages in response to either 
sVSG or mfVSG requires signaling via MyD88. Thus, the release of parasite antigen in 
the time period preceding the first peak of parasitemia stimulates macrophages to produce 
TNF, which in turn contributes to controlling the height of first-peak parasitemia. Lower 
systemic TNF levels present in mice lacking MyD88 is indicative of a failure by the host 
to respond to parasite antigens. However, the activation state of macrophages during 
infection may influence the ability of the host to respond to a Trypanosome infection 
(Coller et ai., 2003). Indeed, macrophage responsiveness towards T. brucei sVSG 
required IFN-y prestimulation, which suggests that direct sensitization of host T cells by 
T. brucei to produce IFN-y occurs before macrophages are fully responsive to sVSG 
(Olsson et ai., 1993). However, IL-12p40-mediated activation of the host T cell 
compartment does not appear to play a crucial role during a T. brucei infection as mice 
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deficient in this cytokine control first-peak parasitemia as well as wild-type controls 
(Table 4.1). In addition, stimulation of macrophages with mfVSG did induce the 
production of IL-12p40, but this response was independent of MyD88-signaling. These 
results suggest that the induction of an IFN-y environment following a T. brucei infection 
is independent of the action of IL-12, as previously shown in experimental infection 
models using T. cruzi (Muller et al., 2001), L. monocytogenes (Brombacher et al., 1999) 
and M tuberculosis (Holscher et aI., 2001), but that the induction of IFN-y requires 
signaling via MyD88. This initial IFN-y environment not only controls first peak 
parasitemia, but also modulates VSG-specific IgM to IgG2a switching (Schopf et al., 
1998), thereby contributing to parasitemia control post first-peak. 
Within this context, MyD88 is required for responsiveness towards IL-l a, IL-I p 
as well as IL-18 (Medzhitov et al., 1998; Wesche et al., 1997; Muzio et al., 1997; Adachi 
et al., 1998). Deficiencies in these cytokines have been associated with a diminished 
capacity to clear intracellular pathogens and fungi (Tsuji et al., 2004; Juffermans et al., 
2000; Mencacci et al., 2000), the reports attributing a reduced early protective response 
to decreased levels ofIFN-y. Mice deficient in IL-IRI and caspase-l were used to control 
for possible decreased responsiveness towards IL-l a, IL-l p and IL-18, respectively. The 
protease caspase-l is required for processing of IL-I p and IL-18 into their biologically 
active forms (Fantuzzi et al., 1999). Infection of mice deficient in either IL-IRI or 
caspase-l showed little or no differences in terms of parasitemia control when compared 
to wild-type animals (Table 4.1), and although a role for MyD88 in IL-I and IL-18 
signaling during infection cannot be excluded, the necessity for these cytokines appear to 
be minimal when compared to TNF and IFN-y. Therefore, we attribute the reduced early 
protective response observed in MyD88-deficient animals to defective Toll signaling. 
However, deficiencies in several individual TLRs failed to reproduce the elevated 
parasitemia levels observed during first-peak parasitemia in MyD88-deficient animals 
(Table 4.1). This would indicate that the control of parasitemia is not dependent on 
activation of an innate immune response via TLRs I, 2 or 4. Although it is possible that 
these receptors function cooperatively with one another in response towards parasite 
components such as sVSG and mfVSG, this study shows no individual role in vivo for 
these receptors either before or after the first peak of parasitemia. However, a partial role 
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for TLR9 was found to contribute to parasitemia control following first peak clearance. 
During this stage of infection, lyses of 108 parasites would release more nuclear material 
into circulation when compared to lyses of parasites before the first peak of infection. 
Here, IL-12p40 produced by macrophages in response to T. brucei DNA could in turn 
induce IFN-y production by PBMC (Shoda et al., 2001), and could account for the 
reduced systemic IFN-y levels found in TLR9-deficient mice following clearance of the 
first peak of parasitemia. In addition to activating macrophages via TLR9, parasite DNA 
may also be involved in triggering B cells to proliferate and differentiate (Shoda et aI., 
2001; Shirota et al., 2002), thereby contributing to the differentiation of Thl cells and 
isotype switching. Therefore, both s VSG and parasitic DNA released systemically during 
infection contribute to macrophage activation and the resulting inflammatory response. 
The extent to which they contribute to macrophage activation and the inflammatory 
response could be more substantially addressed once a receptor for s VSG has been 
identified. This being said, attempts to identifY individual TLRs involved in the activation 
of a protective innate immune response against other parasitic infections have been 
inconclusive. In some cases, purified parasitic components such as T. cruzi-derived GPI 
anchor were shown to activate TLR2 from both mouse and human origin in vitro 
(Campos et al., 2001), although within an in vivo setting, mice deficient in this TLR do 
not display a severely reduced capacity to control a T. cruzi infection compared to mice 
I 
deficient in MyD88 (Campos et al., 2004). Furthermore, in murine infection models 
using P. berghei, T. gondii and L. major, investigators have been unable to formally 
demonstrate that individual, or combinations of TLRs, are involved in innate recognition 
of the aforementioned parasites. 
Although activation of an innate immune response is required to control a T. 
brucei infection, uncontrolled growth of the parasite in the absence of MyD88 is not 
necessarily the causative agent for infection-associated pathology. In this regard, data 
indicates that the general inflammatory state induced by the infection results in 
pathologies such as meningoencephalitis (Okomo-Assoumou et al., 1995) and anemia 
(Magez et al., 1999). Meningoencephalitis is however poorly characterized in mice 
(Sileghem et al., 1995), while the deVelopment of anemia in the mouse model has 
received more attention. Here, studies describing a mechanism for red blood cell lysis 
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have focused on the release of lytic factors by the parasites themselves (Tizard et al., 
1978), antibody-mediated lysis ofRBCs loaded with VSG molecules (Rifkin et al., 1990; 
Rickman & Cox, 1979 & 1980) as well as erythrophagocytosis (Witola et al., 2001). 
However, seeing that the development of anemia corresponds with the general 
inflammatory state induced by the infection, it is not surprising that a role for TNF has 
been found in this process (Sileghem et a!., 1994; Magez et al., 1999). The exact 
mechanism linking TNF to the induction of anemia remains to be shown, but it has been 
postulated that the capacity of ThTF to modulate the activation, growth, and phagocytic 
potential of macrophages links this cytokine to RBC loss through erythrophagocytosis 
(Branch et ai., 1996; Collins et ai., 1992). This finding is however complicated by the 
fact that the level of anemia is influenced by the background of the host (Magez et a!., 
2004; Taiwo et ai., 2000), a result attributed to p75 TNF receptor shedding in a murine 
model as a means to prevent inflammatory pathology (Magez et al., 2004). Results 
presented here expand on the finding that the murine host is not only less anemic in the 
absence of TNF (Fig. 4.4a), but that the development of anemia can be linked to the 
MyD88-dependent activation of macrophages by parasite components such as sVSG and 
mfVSG (Fig. 4.1 & 4.4b). This not only holds true for clonal experimental T. brucei 
infections (Fig. 4.4b), but for non-clonal metacyclic T. brucei infections as well (Fig. 
4.7e). A lesser role in anemia can be attributed to the TLR9-dependent activation of 
macrophages by parasitic DNA (Fig. 4.5), which upon comparison to clonal and non-
clonal infections in MyD88-deficient mice, effects an intermediary phenotype (Fig. 4.6f 
& 4.7f). Therefore, the resulting MyD88-dependent activation of the innate immune 
system by parasite components serves to control parasite numbers, but in doing so 
contributes to the infection-associated pathology as well. 
Collectively, it is likely that the induction of an innate Immune response 
following a T. brucei infection is mediated by interaction between several TLRs that 
signal via MyD88. Indeed, the requirement for the MyD88-dependent activation of an 
innate immune response is far more pronounced in non-clonal T. brucei infections. In the 
field, this would indicate that the VSG repertoire presented by the parasite is far greater, 
emphasizing the requirement for the TLR protein family in initiating an immune 















initially found to confer protection against uropathogenic bacteria (Zhang et al., 2004). 
Although in this paper the phenotype was resticted to the urogenital system, Yarovinsky 
et al. (2005) show that TLR11 is also involved in the recognition of a protozoan profilin-
like protein. Profilin homologs can be found in several apicomplexan parasites including 
T. gondii, P. falciparum, Cryptosporidium parvum, and Eimeria tene/la (Yarovinsky et 
ai., 2005; Rosenberg et al., 2005), and is also present in T. brucei (Wilson et ai., 1997). 
However, it is feasible that recognition of T. brucei is not solely mediated by the TLR 
family, but could include pattern recognition receptors involved in recognizing sugar 
moieties within the variant surface glycoprotein. An example of this type of complex 
formation between the TLR protein family and proteins unrelated to the TLR family 
exists for recognition of endotoxin by the CD14-TLR4-MD2 complex (Miyake et al., 
2004; Akashi et ai., 2003). In the case of T. gondii, parasite-induced IL-12 production by 
DCs was found to be mediated by the dual interaction between My D88 and the C-C 
chemokine receptor 5 (CCR5) (Scanga et ai., 2002; Aliberti et ai., 2000), indicating that 
TLRs function in concert with additional cell-surface receptors to effect the appropriate 
immune response. Analysis of the VSG coat covering T. brucei revealed that the 
galactose side chain composition appears to be important in terms of the TNF-inducing 
capacity of s VSG (Magez et ai., 1998). Thus, while the generation of a protective Type 1 
immune response following a T. brucei infection is MyD88-dependent, it is likely that the 
initial recognition event is mediated by memberls of the TLR family functioning 
cooperatively with a surface protein/s involved in galactose recognition. 
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General discussion & outlook 
The requirement for· TLRs in conferring protective immunity In insects and mICe 
suggested a central role for TLRs in the primary recognition of infectious pathogens 
LeMaitre et ai., 1996; Poltorak et aI., 1998a). An early hypothesis held that individual 
TLR recognized or sensed specific microbial molecules, such that collective TLR 
recognition would enable the host to detect most microbes. Initially, TLR ligand 
specificities were determined using overexpression studies, and although such studies 
revealed useful information about the functioning of signal transduction molecules 
(Takeda et ai., 2003), it was found that the results of these studies might in fact be 
misleading. For example, overexpression studies suggested that TLR2 played a role in 
LPS signaling (Yang et ai., 1998; Kirschning et ai., 1998), a result that was later 
attributed to cell lines becoming extremely sensitive to minor non-LPS contaminants in 
LPS preparations due to the overexpression of TLR2. The more recent advent of TLR 
knockout mice enabled a more thorough characterization of individual TLR ligands 
(Akira et al., 2001). The results obtained from these studies suggested that the individual 
TLR-ligand specificities determined in vitro could be extrapolated to in vivo infectious 
models where the host would require TLRs to initiate an immune response. Collectively, 
the majority of infectious disease models investigating the contribution made by TLR-
signaling in the initiation of immunity have done so using animals deficient in MyD88. In 
mammals, ligand binding by TLRs induces a signaling event that proceeds via MyD88, 
an intracellular adaptor protein. Although the majority of TLRs signal via MyD88, some 
TLRs have also been shown to signal via MyD88-independent pathways (see 
introduction), both of which ultimately induce NF-KB activation. In the work presented 
here, the contribution of TLR signaHng towards the control of infectious diseases is 
assessed in the context of M tuberculosis and T. brucei, addressing the following 
questions: i) during an infection, is the requirement for individual TLRs influenced by the 











dependent activation of an immune response?, and iii) is there a correlation between the 
TLR-dependent control of an infection and immunopathology? 
The requirement for individual TLRs in activating an innate immune response 
does appear to be proportional to the rate of proliferation of the pathogen. This statement 
is corroborated when comparing acute infections caused by bacteria and viruses to more 
chronic infections such as those caused by M tuberculosis and T brucei. For example, in 
acute bacterial and viral infections, individual TLR-deficiencies have been shown to 
severely compromise an innate immune response (Wang et al., 2004; Takeuchi et al., 
2000c; Echchannaoui et al., 2002). In these experimental systems, the rapid induction of 
inflammatory cytokines such as 1NF are essential in controlling these infections which 
indicates that the induction of an inflammatory response by individual TLRs is sufficient 
to control shorter more acute infections. However, when comparing these results to those 
obtained for more chronic infections such as those induced by M tuberculosis and T 
brucei, it appears that collective TLR-signaling is required to elicit a controlled 
inflammatory response. This was corroborated by the fact that animals lacking My D88 
were unable to control either M tuberculosis or T. brucei infections. This being said, 
although collective TLR-signaling is required to control more chronic infections, work 
presented here also shows that specific TLR-signaling is not redundant in such infections. 
It was shown that TLR2 contributed significantly to controlling mycobacterial growth in 
vivo, proving that this TLR is an important member of the TLR family in the context of 
mycobacterial infections. The same was seen for TLR9 and the importance of this TLR in 
controlling growth of the parasite during the more chronic stages of T. brucei infections. 
Thus, there are members of the TLR protein family that have more prominent roles in the 
development of immunity during chronic infections, but it is their collective signaling 
that prevents progression to disease. 
Activation of the immune response by various TLRs is however not solely 
dependent on the pathogen at hand, but appears to be modulated by the initial route of 
infection as well. In the case of M tuberculosis infections, several reports indicate that 
intraperitoneal as opposed to intravenous or aerogenic infection can severly compromise 
the resulting phenotype (Heldwein et al., 2003; Feng et al., 2003; Reiling et al., 2002), a 

















infections (Kropf et al., 2004; Adachi et al., 2001; Scanga et al., 2002; Alexopoulou et 
al., 2002). Delineating the role of individual TLRs in activating an innate immune 
response is therefore made more complicated due to the use of different routes of 
infection, a fact which is more evident in shorter acute infections. For example, animals 
deficient in MyD88 were highly susceptible to an intravenous S. aureus infection 
(Takeuchi et al., 2000C), but resistant to an aerogenic S. aureus challenge (Skerret et al., 
2004). The authors ascribe this discrepancy to the MyD88-independent activation of 
alveolar macrophages and neutrophils which imparts a certain amount of tissue 
specificity towards staphylococcal infections. Secondly, models investigating the role of 
TLRs in the innate recognition of S. pneumonia show that the control of an intranasal 
infection proceeds in a TLR2-independent manner (Knapp et al., 2004), with more 
protection conferred by TLR4 during both nasopharyngeal and intranasal routes of 
infection (Malley et al., 2003; Branger et al., 2004). In contrast, pneumococcal 
meningitis induced by intracerebral injection of S. pneumonia was shown to be TLR2-
dependent (Echchannaoui et al., 2002; Koedel et aI., 2003), which suggests that the role 
of TLR2 in the host response towards S. pneumonia is dependent on the route of 
infection. Thirdly, in infectious studies using the encapsulated yeast Cryptococcus 
neoformans, activation of the immune response was shown to be independent of TLR4 
(Yauch et ai., 2004; Biondo et al., 2005), although significant differences were observed 
in the survival times of wild-type and TLR4-deficient animals infected intraperitoneally 
as opposed to intranasally (Yauch et al., 2004). These results therefore show that the 
initiation of an immune response is also dependent upon the site of infection, and that the 
requirement for individual TLRs in this response varies accordingly. Although this has 
been observed for the TLR -dependent activation of the immune system during acute 
infections, this system of immune activation should be taken into account for pathogens 
. that cause more chronic infections as welL 
In terms of the M tuberculosis model presented here, all infections were initiated 
by delivering the bacillus directly into the lungs, and all conclusions pertaining to the 
TLR-dependent activation of the immune response were based on an experimental set-up 
that closely reflects the natural route of infection. All experiments were performed using 
one strain of M tuberculosis, and although various mycobacterial strains have been 
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shown to influence pathogenesis of the disease (Dormans et al., 2004; Lopez et al., 2003; 
Manabe et a!., 2003), differences in immune responses in the M tuberculosis model were 
not influenced by the use of different strains of M tuberculosis. Such uniformity could 
not be employed in the T brucei model as experiments used to investigate the lLR-
dependent activation of an immune response varied in terms of the parasite strain used, as 
well as the initial route of infection. The differences in progression of infection were 
apparent when comparing the clonal and non-clonal infections. Gene-deficient animals 
infected with non-clonal parasites had higher levels of parasitemia and succumbed to the 
infection before animals infected with clonal stabilates of the parasite. This would 
indicate that the non-clonal form transmitted by the tsetse fly is more virulent than the 
clonal form. However, mice infected with non-clonal parasites had the parasites delivered 
sub-cutaneously or intra-dermally by the fly, while the clonal infections were initiated 
intra-peritoneally. Therefore, in addition to the use of two strains of parasite, the initial 
route of infection with these strains does differ and may contribute to the TLR-dependent 
activation of an immune response. It remains to be determined whether sub-cutaneous as 
opposed to intra-peritoneal T brucei infections elicit a differentiallLR-response in terms 
of the route of infection. However, no differences were observed in terms of the role for 
TLR9 in either clonal or non-clonal infections in that the requirement for this TLR was 
restricted to the second peak of parasitemia, and argues that differing routes of infection 
have little or no effect on the requirement for TLR9 in this model. 
The fact that activation of innate immunity is dependent on both the nature of the 
microbe and the site(s) of infection suggests the preferential activation of different cell 
types in a pathogen- and tissue-specific manner. A recent report describing the in vivo 
production of TNF by specific leukocyte subsets showed that local as opposed to 
systemic TNF production was not only dependent on different cellular subsets, but on the 
physiological location as well as the cellular stimulus used (Grivennikov et al., 2005). 
Here, in an intracellular bacterial model using L. monocytogenes, TNF derived from 
either macrophages or neutrophils was sufficient for protection against a low dose 
infection, with no discemable role for either B- or T-cell-derived TNF. However, a role 
for T -cell-derived TNF became apparent once higher doses of L. monocytogenes were 















intracellular bacterial loads that cannot be solely provided by innate mechanisms. In 
contrast to this, the deleterious role ofTNF in LPS/D-Gal-induced toxic shock was solely 
due to its production by macrophages and neutrophils, with no role for either B- or T-
cell-derived TNF in this process. The corollary with the TLR-dependent activation of 
innate mechanisms becomes more apparent here. In the intracellular bacterial model 
using M tuberculosis, a deficiency in TLR2 impairs the capacity of the macrophage not 
only to produce TNF, but also to kill intracellular bacteria. Once the dose of bacteria is 
increased or uncontrolled due to the defective macrophage compartment, T -cell-derived 
TNF is a function used by the host to control the infection. This was evident in the M 
tuberculosis model where increased levels of pulmonary TNF were associated with an 
increased recruitment of activated T -cells. It remains to be formally demonstrated that 
macrophage-derived TNF plays a more prominent role during pulmonary M tuberculosis 
I 
infection as opposed to T -cell-derived TNF, although a pronounced role for T -cell-
derived TNF was recently shown in long-term mycobacterial infections (Saunders et al., 
2004). These results therefore suggest that T-cells are the major producers ofTNF during 
mycobacterial infections and that a defect at the level of the macrophage results in an 
upregulation of the host T-cell response during an M tuberculosis infection. In the model 
investigating innate mechanisms required to control the extracellular parasite T. brucei, 
data presented here shows that macrophages require TLRs to produce TNF in response to 
parasite antigens. This inflammatory response is however restricted to the macrophage as 
it is macrophage-derived TNF and not T-cell-derived TNF that is responsible for control 
of parasitemia (unpublished observations). Therefore, control of parasitemia appears to 
be dependent on the production of TNF by macrophages and not T -cells, thereby more 
closely resembling the model of LPS/D-Gal-induced toxic shock (Grivennikov et al., 
2005). Collectively, these results indicate that recognition of both M tuberculosis and T. 
brucei is initially orchestrated by the macrophage, but that the major cellular producers of 
TNF are T -cells during mycobacterial infections and macrophages during T. brucei 
infections. 
Although the induction of TNF is associated with a protective immune response 
in an infectious setting, the cytokine has been implicated in pathology associated with 















contributing to swel1ing, tissue injury and influx of immunologically active cells. 
Although treatment of inflammatory diseases caused by sterile inflammation initially 
focused on the blockade of cytokines such as 1NF, new approaches are leaning towards 
comprehensive 'upstream' blockade of signaling molecules such as TLRs (Ulevitch, 
2004). These strategies not only apply to the downregulation of TLR function in the 
context of pathologies such as sepsis and autoimmune disease, but also extend to the 
upregulation of TLR function in diseases such as cancer, allergy and disease epidemics. 
However, the specific targeting of innate immune pathways such as TLRs as a means to 
control pathologies induced by diseases such as autoimmunity and sterile inflammation 
should be approached with caution. Work presented here shows that manipulation of host 
TLR-signaling pathways can result in both uncontrolled disease progression as well as 
infection-induced immunopathology. In the model of M tuberculosis, deletion of TLR2 
impaired the immune response such that the host attempted to compensate for this 
deficiency by upregulating an inflammatory response. The resulting pulmonary 
phenotype was one similar to that observed for sterile inflammation, namely tissue injury 
and an influx of immunologically active cells. In terms of the T brucei model, blocking 
TLR signaling certainly reduced the infection-associated anemia, but also resulted in the 
inability of the host to control growth of the parasite. Collectively, these results indicate 
that the blockade of TLR signaling as a means to quell pathologies such as those caused 
by sterile inflammation would ultimately endanger the host's ability to control infectious 
disease. This would not only apply to pathogens that cause acute infections, but should be 
taken into account for pathogens that cause more chronic infections as well. 
The work presented in this thesis therefore shows that the mammalian host 
requires TLRs to recognize molecular structures present on M tuberculosis and T brucei. 
Infection of the host with either pathogen showed that the innate immunological response 
initiated by TLR signaling regulated the adaptive immune response during the chronic 
stages of infection. Furthermore, results presented here show that although the TLR-
dependent activation of an immune response was dynamic enough to eliminate the 
pathogen, this response can be responsible for the development of immunopathology as 
well. 
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